Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1050.Time spend outdoors in summer,50090,-0.00116599264757797,0.0209509166826944,-0.042229789345659,0.039897804050503,0.955618330425999
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1060.Time spent outdoors in winter,47912,-0.0075962327594874,0.0231744602776911,-0.053018174903762,0.0378257093847872,0.743078034360847
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X1070.Time spent watching television (TV),50887,-0.0165662979731078,0.0205165091766486,-0.0567786559593391,0.0236460600131235,0.419409076799156
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X1080.Time spent using computer,47944,-0.0203620555118376,0.0206375951301848,-0.0608117419669997,0.0200876309433245,0.32382724952953
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X1090.Time spent driving,45241,-0.0551450769342395,0.0227005981575468,-0.0996382493230312,-0.0106519045454478,0.0151412545580621
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1160.Sleep duration,51954,0.0699845033464827,0.0189468018105538,0.0328487717977973,0.107120234895168,0.000221486178091689
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,35970,0.00026114548721449,0.0239837715285511,-0.0467470467087457,0.0472693376831747,0.991312760516988
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,35970,0.021743521608763,0.0266805959714057,-0.0305504464951921,0.0740374897127181,0.415123618896489
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,35970,-0.00584860668740262,0.0280780522297307,-0.0608815890576748,0.0491843756828696,0.835001922175957
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,35970,0.0582221596758748,0.0290209760526042,0.00134104661277056,0.115103272738979,0.0448703654228205
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,35970,0.091667889823309,0.0298068843810275,0.0332463964364951,0.150089383210123,0.00210995058297722
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,35970,0.0554605416029259,0.0804948588274197,-0.102309381698817,0.213230464904668,0.49084820995508
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,35970,0.0251783572311764,0.0934032274403055,-0.157891968551822,0.208248683014175,0.787501519014721
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,35970,0.0139316082607287,0.046806035985435,-0.077808222270724,0.105671438792181,0.765982095909091
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,35970,0.0366164314753004,0.0360238582906852,-0.0339903307744427,0.107223193725043,0.309448766999876
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,35970,0.0325906080425547,0.0241848288203119,-0.0148116564452567,0.0799928725303661,0.177840034269474
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,35970,0.0123544125679962,0.0381907357798014,-0.0624994295604145,0.087208254696407,0.746331544853003
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,35970,0.0189834652524374,0.0180950844010107,-0.0164829001735435,0.0544498306784183,0.294168729288056
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,35970,0.0321078425979657,0.0247363032133135,-0.0163753117001287,0.08059099689606,0.194326273224064
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,35970,0.0852310658932448,0.0391767261472761,0.00844468264458363,0.162017449141906,0.0296203301713856
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,35970,0.0112605430218617,0.0362374451406347,-0.0597648494537822,0.0822859354975057,0.756004570201372
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,35970,0.0311977713935129,0.0442738211499623,-0.0555789180604132,0.117974460847439,0.481047200680189
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,35970,0.0217913278220871,0.0432341623496798,-0.0629476303832853,0.106530286027459,0.614255151096678
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,35970,0.0358982717692521,0.027742880614829,-0.0184777742358127,0.090274317774317,0.195718614596759
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,35970,0.00426453650634297,0.0270609354822842,-0.048774897038934,0.0573039700516199,0.874784093806844
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,35970,-0.0169567684488767,0.0301155863197999,-0.0759833176356845,0.0420697807379311,0.573413724257751
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120040.Fatigue severity over the past week,35976,0.0555740420842393,0.0357687056915038,-0.0145326210711083,0.125680705239587,0.120297546365164
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120041.Waking unrefreshed severity over the past week,35979,0.0354171159860335,0.035074903622251,-0.0333296951135784,0.104163927085645,0.312645028219203
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120042.Cognitive symptoms severity over the past week,35979,0.0396944237674495,0.0387175393882764,-0.0361919534335722,0.115580800968471,0.305287794512426
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120098.Mobility problems today,35981,0.0860460847541775,0.0416553358305042,0.00440162652638926,0.167690542981966,0.0388946971444749
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120099.Self-care problems today,35981,0.0104233780303693,0.0629524894704572,-0.112963501331727,0.133810257392465,0.868495714455276
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120100.Problems doing usual activities,35981,0.092707288504475,0.0402141073515537,0.0138876380954297,0.17152693891352,0.0211750117011349
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120101.Pain or discomfort today,35981,0.0433934495230426,0.0355134676653257,-0.0262129471009957,0.112999846147081,0.221789345466859
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120102.Anxiety or depression today,35981,-0.00651963252151949,0.045305682551104,-0.0953187703216833,0.0822795052786443,0.885580841971418
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120103.Scale to indicate how health is today,35963,-0.015239781535943,0.00789136687253181,-0.0307068606061053,0.00022729753421937,0.0534970722385212
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,35965,-0.0214259669234563,0.0442585963313037,-0.108172815732812,0.065320881885899,0.628323199453335
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",35963,-0.0321116410528978,0.0470736799662781,-0.124376053786803,0.0601527716810072,0.495161135108773
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",35969,-0.00453067457163688,0.0357348769955996,-0.0745710334830121,0.0655096843397383,0.899113403857337
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,35974,0.085756932342395,0.0365491379814682,0.0141206218987173,0.157393242786073,0.0189848250284447
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,35973,0.0264487622088452,0.0520574552710366,-0.0755838501223866,0.128481374540077,0.611420387402093
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120109.Feeling bad about self over the last two weeks,35956,-0.0708659353770032,0.0494459480906762,-0.167779993634728,0.0260481228807221,0.151843185055451
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120110.Trouble concentrating over the last two weeks,35976,-0.0127966325984227,0.0472986532576714,-0.105501992983459,0.0799087277866132,0.786745021335543
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,35968,0.03566643556373,0.0690489164150503,-0.0996694406097686,0.171002311737229,0.605493743318233
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,35934,-0.0691011636300311,0.0967361112999533,-0.25870394177794,0.120501614517877,0.475048076286646
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",33192,0.00275319079472748,0.0509157541221031,-0.0970416872845946,0.10254806887405,0.95687899354617
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49461,0.0514090054549228,0.0459898506407103,-0.0387311018008695,0.141549112710715,0.263650893931098
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,48240,0.00866301909647372,0.0263443242810709,-0.0429718564944253,0.0602978946873727,0.742281525192712
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1289.Cooked vegetable intake,51020,-0.0145494620825686,0.0196784195779156,-0.0531191644552831,0.024020240290146,0.459695370309414
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50187,-0.0298434700760967,0.0203291222207165,-0.069688549628701,0.0100016094765076,0.142114535691126
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1309.Fresh fruit intake,50875,0.0831165295552182,0.0208721596537278,0.0422070966339116,0.124025962476525,6.85051199432712e-05
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1319.Dried fruit intake,49899,0.0621096367032569,0.0222192853322669,0.0185598374520137,0.1056594359545,0.00518974773031141
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X134.Number of self-reported cancers,52103,0.0630162759277904,0.0417092898319263,-0.0187339321427852,0.144766483998366,0.130841368142234
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X135.Number of self-reported non-cancer illnesses,52104,0.097242965886184,0.0197165766603106,0.0585984756319752,0.135887456140393,8.19299414767274e-07
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X136.Number of operations, self-reported",52104,0.0725011298012404,0.0189115990795114,0.0354343956053982,0.109567863997083,0.000126566299035601
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X137.Number of treatments or medications taken,52104,0.198091590223941,0.0193235045504363,0.160217521305086,0.235965659142796,1.31524416690668e-24
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1438.Bread intake,51550,0.0276405738244919,0.00435083339624833,0.0191129403678452,0.0361682072811386,2.15205500403812e-10
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1458.Cereal intake,50896,0.151638717183671,0.0195863298296035,0.113249510717648,0.190027923649694,1.01961271778382e-14
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1488.Tea intake,51238,0.011222631325999,0.00428170759155058,0.00283048444655985,0.0196147782054381,0.00877142837018354
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1498.Coffee intake,50288,0.045785341311018,0.0197159174893448,0.00714214303190225,0.0844285395901338,0.0202285466615179
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1528.Water intake,49961,0.0497751411716791,0.0199977636690633,0.010579524380315,0.0889707579630432,0.0128165749702705
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1568.Average weekly red wine intake,46503,-0.191579915408249,0.0220196551780568,-0.23473843955724,-0.148421391259257,3.58923742820101e-18
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,46494,-0.0658523368475969,0.0228510638450191,-0.110640421983834,-0.0210642517113594,0.0039587313364554
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1588.Average weekly beer plus cider intake,46567,-0.180127173044626,0.0229021691428512,-0.225015424564615,-0.135238921524638,3.89681614467965e-15
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1598.Average weekly spirits intake,46498,-0.0732721146934601,0.0237494480637994,-0.119821032898507,-0.0267231964884133,0.00203716342909363
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1608.Average weekly fortified wine intake,46535,0.000939854393295159,0.0423481780777878,-0.082062574639169,0.0839422834257593,0.982293847527722
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1737.Childhood sunburn occasions,45893,-0.0174131325869318,0.0230135405563658,-0.0625196720774088,0.0276934069035452,0.449271523326511
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X1807.Father's age at death,46092,-0.00450047552448087,0.00491181661337889,-0.0141276360867035,0.00512668503774176,0.359545903295904
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X1845.Mother's age,37262,-0.002225187976356,0.0114405360239973,-0.0246486385833907,0.0201982626306787,0.84578870245686
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X1873.Number of full brothers,51693,0.0220459872437648,0.0188734378234412,-0.01494595089018,0.0590379253777097,0.242780102966235
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X1883.Number of full sisters,51696,0.0421367696908232,0.0190191495404316,0.00485923659157738,0.0794143027900691,0.0267360429017121
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X20015.Sitting height,51896,-0.0212350902653267,0.00562519961798264,-0.0322604815165727,-0.0102096990140807,0.000160408945116818
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20016.Fluid intelligence score,36112,-0.0514860355144009,0.0305806390763307,-0.111424088104009,0.00845201707520737,0.0922976323110605
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20018.Prospective memory result,36454,0.167274279409563,0.0416617377976258,0.0856172733262168,0.24893128549291,5.99845241102894e-05
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),36023,0.0153237918859429,0.00780506039866118,2.58735045669482e-05,0.0306217102673188,0.0496468654114002
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),36022,0.0346716786896027,0.00781596996795009,0.0193523775524206,0.0499909798267849,9.29657125974669e-06
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20023.Mean time to correctly identify matches,51795,0.0117881506923034,0.00442826458542338,0.00310875210487358,0.0204675492797332,0.00777256734991043
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#1.Illnesses of father_Heart disease,48672,-0.00363058588206604,0.00981665849550937,-0.0228712365332644,0.0156100647691323,0.711506149896611
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48229,-0.0392757696410196,0.0221744225458721,-0.0827376378309289,0.00418609854888979,0.0765397216539339
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48189,0.014734945754189,0.0290960487583687,-0.0422933098122138,0.0717632013205917,0.612564527792837
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#12.Illnesses of father_Severe depression,48213,-0.032031235288111,0.0260900983953042,-0.0831678281429072,0.0191053575666853,0.219568274050868
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48235,-0.0241816967226252,0.0174279285198748,-0.0583404366215799,0.00997704317632952,0.165297301516539
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#2.Illnesses of father_Stroke,48406,-0.00376241704246557,0.012536020476997,-0.0283330171773797,0.0208081830924485,0.764082289394798
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48355,-0.0281134621684253,0.0158713961455137,-0.0592213986136321,0.00299447427678146,0.0765214441467476
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48250,-0.0125046528854281,0.0193048574279666,-0.0503421734442426,0.0253328676733865,0.517156522892972
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48371,0.00357785270949047,0.0149005351895114,-0.025627196261952,0.0327829016809329,0.810243038603857
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48464,-0.00731678378283729,0.0111147759775048,-0.0291017446987466,0.0144681771330721,0.51035724076858
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#9.Illnesses of father_Diabetes,48321,0.0274641489404884,0.0153268107739529,-0.00257640017645935,0.0575046980574362,0.0731639272723668
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,49446,0.0108389887180837,0.0117260024441296,-0.0121439760724103,0.0338219535085778,0.355312227314342
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49283,0.00620785614964824,0.0165035007990541,-0.0261390054164978,0.0385547177157943,0.706806345219505
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49207,-0.0207637705168949,0.0365497432360307,-0.092401267259515,0.0508737262257252,0.569975832611197
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49241,-0.0140433421845506,0.0194569304904587,-0.0521789259458495,0.0240922415767484,0.470446807517836
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#2.Illnesses of mother_Stroke,49391,0.00429279785955079,0.0131492624830861,-0.021479756607298,0.0300653523263996,0.744074478001237
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49280,0.00860439824151126,0.0221584292116269,-0.0348261230132775,0.0520349194963001,0.697788678411412
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49250,-0.00380167379314537,0.0200281886760199,-0.0430569235981444,0.0354535760118537,0.849455060813048
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49259,-0.0124776795138207,0.0167877758544293,-0.0453817201885021,0.0204263611608608,0.457332835586094
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49293,-0.024870189362341,0.0200749798514702,-0.0642171498712225,0.0144767711465405,0.215409559531642
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,49492,0.00805934871505455,0.0101009038058596,-0.0117384227444304,0.0278571201745395,0.424946924760918
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49341,0.0395544787056418,0.0151792584214902,0.00980313219952102,0.0693058252117626,0.00917189752244915
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46426,0.0206122816116104,0.0161882222654239,-0.0111166340286205,0.0523411972518413,0.202932194013715
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46282,0.125532463407019,0.0660058155264909,-0.00383893502490359,0.254903861838941,0.0572083836517069
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46274,-0.0268486661178121,0.0643403464666925,-0.152955745192529,0.0992584129569053,0.676470427833071
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46330,0.0280865479832011,0.0211950441387364,-0.0134557385287222,0.0696288344951244,0.18513949479749
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46292,0.0321811711519238,0.0375526598490237,-0.0414220421521627,0.10578438445601,0.391477954566362
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46327,0.0799638488243801,0.0269740484090745,0.027094713942594,0.132832983706166,0.00303604855245893
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46296,-0.000273828745158075,0.0309374494417112,-0.060911229650912,0.0603635721605958,0.992938080138748
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46300,0.0130976865765976,0.0301429070044875,-0.045982411152198,0.0721777843053932,0.66391639734686
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46308,0.00424903119256468,0.0238339096905958,-0.0424654318010031,0.0509634941861325,0.858507701728549
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46324,0.0523742281492389,0.030255777433537,-0.00692709562049353,0.111675551918971,0.0834604584975977
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46494,0.00407030149505557,0.012320413859293,-0.0200777096691587,0.0282183126592698,0.741123883922379
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46389,0.0655487569493488,0.0171808600500522,0.0318742712512464,0.0992232426474511,0.000136521906059032
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20127.Neuroticism score,47543,0.0415963284888255,0.0196732402198274,0.00303677765796372,0.0801558793196872,0.0344974967389466
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,36112,0.0225489397129069,0.0310831681240639,-0.0383740698102583,0.0834719492360721,0.468205438559206
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X20161.Pack years of smoking,36783,0.0134949406522551,0.00743640299054174,-0.00108040920920673,0.0280702905137169,0.0696045522342192
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,36783,0.0133101846325543,0.00732966012054858,-0.00105594920372096,0.0276763184688295,0.0694169586531115
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20191.Fluid intelligence score,34206,-0.0105744838626443,0.0367472067262797,-0.0825990090461525,0.0614500413208639,0.773538875346057
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,34207,-0.0177567200076996,0.0375214399266257,-0.0912987422638859,0.0557853022484867,0.636059022778939
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20240.Maximum digits remembered correctly,33672,-0.0338832084901697,0.0397398023765649,-0.111773221148237,0.0440068041678974,0.393906786695363
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X20255.Spirometry QC measure,45386,0.0302144045603391,0.0242246823850295,-0.0172659729143187,0.0776947820349968,0.212320679604756
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X20261.avMSE,33765,-0.0125609917288182,0.00978836444272636,-0.0317461860365619,0.00662420257892546,0.199459463829009
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X20262.Myopia diagnosis,33765,0.0840212336436596,0.0465348771583374,-0.00718712558668162,0.175229592874001,0.0710462461881316
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X20280.Glucose-lactate,41989,-0.0200889808083603,0.0055185836965124,-0.0309054048535246,-0.00927255676319601,0.000273407822281102
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X20281.Spectrometer-corrected alanine,42014,0.0359346392947858,0.00583086045777858,0.0245061527975398,0.0473631257920319,7.34993430461704e-10
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,35868,0.0224069299615544,0.0365473387829023,-0.0492258540529341,0.0940397139760428,0.53983380847865
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,35868,0.0408030335105929,0.0802294334957,-0.116446656140979,0.198052723162165,0.611062539875681
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),35867,0.00461693256197345,0.0995521573362834,-0.190505295817142,0.199739160941089,0.963011025165134
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),35867,0.00377810339768195,0.0356559999660529,-0.0661076565357817,0.0736638633311456,0.915617154953387
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),35867,-0.0716749360326148,0.0503360109940317,-0.170333517580917,0.0269836455156874,0.154509787147627
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,35870,0.0393014864872204,0.0687057227143698,-0.0953617300329444,0.173964703007385,0.567321783112256
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,35870,0.0168178576929504,0.0430817640587111,-0.0676223998621234,0.101258115248024,0.696273899932809
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,35870,0.00372274380213496,0.0489984634554738,-0.0923142445705936,0.0997597321748635,0.939439689454485
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,35870,0.0476030708470222,0.0714731671877833,-0.0924843368410331,0.187690478535078,0.505414870132102
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,35870,0.0332257279112187,0.0808342258607246,-0.125209354775801,0.191660810598239,0.681058696531208
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,35870,-0.0254332784289716,0.05227866613713,-0.127899464057746,0.0770329071998032,0.626631338101938
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,35870,-0.0237993967885903,0.0780490214332435,-0.176775478797748,0.129176685220567,0.760429086474952
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,35870,0.0757698177740171,0.0627796460088258,-0.0472782884032815,0.198817923951316,0.227503404459943
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),35873,0.0664592559204589,0.106955512136099,-0.143173547866294,0.276092059707212,0.534373777906259
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),35873,0.0125883118710861,0.046889175316921,-0.0793144717500791,0.104491095492251,0.788345589091807
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),35873,-0.0678015998488768,0.0617901373840879,-0.188910269121689,0.0533070694239355,0.272551675788224
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,35873,-0.00826119094163137,0.129403939103796,-0.261892911585072,0.24537052970181,0.949099114756678
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20600.Liking for adding salt to foods,36556,-0.0204948640228668,0.0310481294560198,-0.0813491977566656,0.040359469710932,0.509208918224713
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20601.Liking for aniseed,36556,-0.0433772386630165,0.0308531810872766,-0.103849473594079,0.0170949962680457,0.15978568480586
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20602.Liking for apple juice,36556,0.0488978935012885,0.0309834853757268,-0.0118297378351361,0.109625524837713,0.114561273303465
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20603.Liking for apples,36556,0.00528205029830128,0.031455385833979,-0.0563705059362976,0.0669346065329002,0.866648940418904
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20604.Liking for asparagus,36556,-0.0561612410178643,0.0309313853653351,-0.116786756333921,0.00446427429819249,0.0694584174195616
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20605.Liking for aubergine,36556,-0.0515268520822296,0.0308557457299759,-0.112004113712982,0.00895040954852325,0.09497313152926
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20606.Liking for avocados,36556,-0.0176344651280424,0.0307115916451917,-0.0778291847526182,0.0425602544965333,0.565851602225967
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20607.Liking for bacon,36556,-0.0287019190227557,0.0313670678940613,-0.0901813720951159,0.0327775340496045,0.360201788076202
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20608.Liking for baked or steamed fish,36556,0.00787649683536399,0.0310726265756085,-0.0530258512528286,0.0687788449235566,0.799898712978257
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20609.Liking for bananas,36556,0.0541209209793928,0.0316732685482939,-0.00795868537526324,0.116200527334049,0.0875408594764435
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,36556,-0.0418172956291622,0.0312939123863013,-0.103153363906313,0.0195187726479883,0.181497425473753
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20611.Liking for beef steak,36556,-0.0258726316680791,0.0313240340387074,-0.0872677383839456,0.0355224750477874,0.408847367183866
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20612.Liking for beetroot,36556,-0.00309298558836885,0.0312002508101582,-0.0642454771762789,0.0580595059995412,0.921034888178385
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20613.Liking for bell pepper,36556,-0.0932523977845579,0.030893702645092,-0.153804054968938,-0.0327007406001776,0.00254841670876168
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20614.Liking for bicycling,36556,-0.0340737035637858,0.0311551588551786,-0.0951378149199358,0.0269904077923642,0.27412949196174
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20615.Liking for biscuits,36556,0.123858311191678,0.0310785830978194,0.0629442883199521,0.184772334063404,6.79899279670325e-05
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20616.Liking for bitter foods,36556,-0.127462718089517,0.0310069236127182,-0.188236288370445,-0.0666891478085893,3.98288128810437e-05
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20617.Liking for bitter or ale,36556,-0.258602322277514,0.0311534775485264,-0.319663138272625,-0.197541506282402,1.20369313157024e-16
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20618.Liking for black olives,36556,-0.102195275930366,0.0309648502855482,-0.162886382490041,-0.0415041693706919,0.000969849414368174
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20619.Liking for black pepper,36556,-0.145406428962281,0.0314908701816588,-0.207128534518332,-0.0836843234062299,3.94654434142999e-06
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20620.Liking for blue cheese,36556,-0.0755372306318023,0.0310681878822591,-0.13643087888103,-0.0146435823825744,0.0150651769880081
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20621.Liking for bolognese sauce,36556,-0.0655924780413188,0.0314958764916466,-0.127324395964946,-0.00386056011769154,0.0373220187717136
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20622.Liking for broad beans,36556,-0.0401704690189871,0.030923375276146,-0.100780284560233,0.020439346522259,0.193970468600013
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20623.Liking for broccoli,36556,-0.0172588351974628,0.0313733633127254,-0.0787506272904046,0.044232956895479,0.58225863875771
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20624.Liking for brown rice,36556,0.0270730269921902,0.0307691143119007,-0.0332344370591353,0.0873804910435156,0.378952709786132
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20625.Liking for brussel sprouts,36556,-0.00171274290314233,0.0309060612764147,-0.0622886230049151,0.0588631371986305,0.955807086214511
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20626.Liking for burgers (meat),36556,0.000418876808303852,0.0309291590838209,-0.0602022749959851,0.0610400286125928,0.989194836943482
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20627.Liking for burn of spicy foods,36556,-0.101976982647127,0.0309400498464327,-0.162619480346135,-0.0413344849481185,0.00098518081714579
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20628.Liking for butter on bread,36556,0.0459961649796833,0.0313580355746793,-0.015465584746688,0.107457914706055,0.142468317663434
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20629.Liking for butternut squash,36556,0.0169994333107802,0.0308646925002248,-0.0434953639896604,0.0774942306112208,0.581804909871489
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20630.Liking for cabbage,36556,0.00463404814493399,0.0310959263034059,-0.0563139674097415,0.0655820636996095,0.881538252583222
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20631.Liking for cake,36556,0.164898794147561,0.0314752901918938,0.103207225371449,0.226590362923673,1.65600266436932e-07
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20632.Liking for cake icing,36556,0.0989869977173972,0.030971797415226,0.0382822747835542,0.15969172065124,0.00139874548707087
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20633.Liking for capers,36556,-0.112713261686796,0.0312164126803021,-0.173897430540188,-0.0515290928334039,0.000307246857873586
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20634.Liking for cauliflower,36556,-0.00517362777708666,0.0312564991644441,-0.066436366139397,0.0560891105852237,0.868537609293507
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20635.Liking for cereal or granola bar,36556,0.0720910705655895,0.0307680302831319,0.011785731210651,0.132396409920528,0.0191512861645251
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20636.Liking for cheesecake,36556,0.109458656553539,0.0312115069761884,0.0482841028802098,0.170633210226868,0.000455697716817107
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20637.Liking for cherries,36556,0.0179937815259519,0.0314524798174724,-0.043653078916294,0.0796406419681977,0.567274334923512
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20638.Liking for chicken,36556,-0.0326249270448219,0.0321338788805226,-0.0956073296506463,0.0303574755610025,0.310002653800599
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20639.Liking for chilli pepper,36556,-0.163921958711664,0.0311110851521255,-0.22489968560983,-0.102944231813498,1.40827093683426e-07
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20640.Liking for chips or french fries,36556,0.03525923982496,0.0312883294281126,-0.0260658858541407,0.0965843655040606,0.259813093905154
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20641.Liking for cigarette smoking,36556,-0.0872305900838446,0.0490736106086661,-0.18341486687683,0.00895368670914108,0.0755167171604887
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20642.Liking for cod,36556,0.00774512756322269,0.0318033000199074,-0.0545893404757959,0.0700795956022412,0.807599431152026
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20643.Liking for coffee with sugar,36556,0.0549436070665069,0.0323805922160918,-0.00852235367703306,0.118409567810047,0.0897723644712214
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20644.Liking for coffee without sugar,36556,-0.0304752553995489,0.031196118447357,-0.0916196475563687,0.0306691367572709,0.328652090898703
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20645.Liking for coriander,36556,-0.0909869641105379,0.0310323711133296,-0.151810411492664,-0.030163516728412,0.0033774553071393
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20646.Liking for corn flakes,36556,0.0765412620204642,0.0309452012703367,0.0158886675306043,0.137193856510324,0.0134024770383049
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20647.Liking for cream,36556,0.0726452548384955,0.030762064437676,0.0123516085406506,0.13293890113634,0.0182241391671235
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20648.Liking for croissant,36556,0.0360344539325495,0.0308495523019097,-0.0244306685791936,0.0964995764442926,0.242813344073162
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20649.Liking for cucumber,36556,-0.0186012959990993,0.0309307696640242,-0.0792256045405868,0.0420230125423882,0.547600846490202
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20650.Liking for curry,36556,-0.0985206336708243,0.0313995004814712,-0.160063654614508,-0.0369776127271407,0.00170930819309716
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20651.Liking for dairy products,36556,0.132984368786738,0.0314981702618132,0.0712479550735837,0.194720782499891,2.44873033802918e-05
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20652.Liking for dark chocolate,36556,0.0628632271499704,0.0308735233874683,0.00235112131053261,0.123375332989408,0.0417680526731636
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20653.Liking for diet fizzy drinks,36556,0.0650845410594753,0.0316597711294267,0.003031389645799,0.127137692473152,0.0398393181658126
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20654.Liking for dried fruit,36556,0.034040108239477,0.0310090991826269,-0.0267377261584717,0.0948179426374257,0.272348765655409
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20655.Liking for eggs,36556,-0.00567927941927095,0.0317487914432081,-0.0679069106479588,0.0565483518094169,0.858035111929611
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20656.Liking for exercising alone,36556,0.00684812849904149,0.0308925265516277,-0.0537012235421487,0.0673974805402317,0.824571891346262
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20657.Liking for exercising with others,36556,-0.000705741844202501,0.0310403234866824,-0.0615447758781001,0.0601332921896951,0.981861197674273
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20658.Liking for extra virgin olive oil,36556,-0.0764656845071191,0.0312187748527129,-0.137654483218436,-0.0152768857958017,0.0143328953100418
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20659.Liking for fatty foods,36556,0.0242673009599595,0.0310461697688036,-0.0365831917868955,0.0851177937068145,0.434442399030292
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20660.Liking for fresh tomatoes,36556,-0.0119386587165105,0.0320008439896523,-0.0746603129362289,0.0507829955032079,0.709103880982167
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20661.Liking for fried chicken,36556,0.00122604342953611,0.0309716991407144,-0.0594784868862641,0.0619305737453363,0.968424241434861
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20662.Liking for fried or battered fish,36556,0.0326501798533036,0.0313851011357559,-0.028864618372778,0.0941649780793851,0.298228357625964
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20663.Liking for fruit,36556,-0.0118153841076905,0.0327831513178933,-0.0760703606907614,0.0524395924753805,0.718549933213426
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20664.Liking for garlic,36556,-0.0555319090328384,0.0314332593516068,-0.117141097361988,0.00607727929631083,0.0773234220844972
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20665.Liking for gherkins,36556,-0.0638223854291797,0.0307565124923854,-0.124105149914255,-0.00353962094410433,0.0380107328699216
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20666.Liking for globe artichoke,36556,-0.114252659433003,0.031181335611527,-0.175368077231596,-0.0531372416344098,0.000249790330026914
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20667.Liking for goat's cheese,36556,-0.00657208613299116,0.0308674930102691,-0.0670723724331185,0.0539282001671362,0.83140039479823
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20668.Liking for going to a cafe,36556,0.0956175132448456,0.0310564346635612,0.0347469013042656,0.156488125185426,0.00208523168950619
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20669.Liking for going to the gym,36556,-0.000305366211401054,0.0307136924498876,-0.0605042034131808,0.0598934709903787,0.992067534477532
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20670.Liking for going to the pub,36556,-0.283021627516057,0.031039951257357,-0.343859931980477,-0.222183323051637,9.54779649916289e-20
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20671.Liking for grapefruit,36556,-0.017681308930736,0.0306632062676795,-0.0777811932153878,0.0424185753539158,0.56420610637318
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20672.Liking for green olives,36556,-0.103915685616397,0.0311006052158994,-0.164872871839559,-0.0429584993932337,0.000837790811330982
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20673.Liking for haddock,36556,-0.0444601148557449,0.0316522956649763,-0.106498614359098,0.0175783846476086,0.160167116961609
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20674.Liking for ham,36556,-0.0422563493656518,0.0312990924067531,-0.103602570482888,0.0190898717515842,0.177028048192721
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20675.Liking for hard cheese,36556,-0.0165808487853883,0.0318493801597355,-0.0790056338984699,0.0458439363276933,0.602658608070825
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20676.Liking for herring,36556,-0.0177501695525899,0.0308979531812468,-0.0783101577878336,0.0428098186826538,0.565661187219321
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20677.Liking for honey,36556,0.0507605686125977,0.0313563919910151,-0.010697959689792,0.112219096914987,0.10552421004697
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20678.Liking for horseradish or wasabi,36556,-0.0865572053802174,0.0309899165541516,-0.147297441826354,-0.0258169689340804,0.00523342449452765
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20679.Liking for ice cream,36556,0.0698628344544561,0.0315042325516526,0.00811453865321708,0.131611130255695,0.0266123577830201
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20680.Liking for jam,36556,0.0643708840639019,0.0310347775759296,0.00354272001507992,0.125199048112724,0.0380972051982148
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20681.Liking for kiwi fruit,36556,0.00266151616244741,0.0310369953975455,-0.0581709948167417,0.0634940271416366,0.931664911773354
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20682.Liking for lager,36556,-0.142605347763875,0.0309067934591835,-0.203182662943875,-0.0820280325838755,4.01093997025915e-06
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20683.Liking for lamb,36556,-0.0217683366857441,0.0312488951436714,-0.08301617116734,0.0394794977958518,0.486066392262355
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20684.Liking for lemons,36556,-0.0976112456001015,0.0309779230198567,-0.158327974719021,-0.0368945164811824,0.00163320059895656
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20685.Liking for lentils or beans,36556,-0.0697121081156026,0.0311459708711863,-0.130758211023128,-0.00866600520807746,0.025233096552898
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20686.Liking for liver,36556,-0.029111395388685,0.031050181539231,-0.0899697512055777,0.0317469604282078,0.348499279580415
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20687.Liking for mackerel,36556,-0.00698009526329144,0.0309637134006394,-0.0676689735285447,0.0537087830019618,0.821651945015326
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20688.Liking for marzipan,36556,0.143159340783354,0.0310022361574888,0.0823949579146762,0.203923723652032,3.94095940358862e-06
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20689.Liking for mayonnaise,36556,0.0202281054951462,0.0310282386302186,-0.0405872422200823,0.0810434532103748,0.51446797277059
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20690.Liking for melon,36556,-0.0385073712010298,0.0314171870100104,-0.10008505774065,0.0230703153385906,0.220355998499303
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20691.Liking for milk chocolate,36556,0.00444298383947315,0.0310801561814056,-0.0564741222760818,0.0653600899550281,0.886331375060322
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20692.Liking for mushrooms,36556,-0.0291144838973947,0.0316528070480259,-0.0911539857115254,0.032925017916736,0.357701371045227
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20694.Liking for orange juice,36556,0.0111458549882035,0.031021979990348,-0.0496572257928787,0.0719489357692856,0.719388476666158
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20695.Liking for oranges,36556,0.00349901846981107,0.0313928224104644,-0.0580309134546992,0.0650289503943213,0.911255042600595
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20696.Liking for pasta,36556,-0.0410493788496484,0.031499214267555,-0.102787838814056,0.0206890811147593,0.192548549263492
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20697.Liking for pears,36556,0.0110731921651582,0.0313226360027681,-0.0503191744002674,0.0724655587305837,0.723707682933465
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20698.Liking for pizza,36556,0.00778893822431773,0.0311706429608939,-0.0533055219790342,0.0688833984276697,0.802686163489212
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20699.Liking for plain yogurt,36556,0.0155460967560803,0.0308762782561776,-0.0449714086260279,0.0760636021381884,0.614629225019248
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20700.Liking for plums,36556,0.0311970476479791,0.0311969277271868,-0.029948930697307,0.0923430259932653,0.317339094816752
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20701.Liking for pollock,36556,-0.0251984323054775,0.0309823509582842,-0.0859238401837145,0.0355269755727595,0.416061446492346
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20702.Liking for pork chop,36556,0.010852713843447,0.0311017186284618,-0.0501066546683382,0.0718120823552322,0.72714166451282
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20703.Liking for porridge,36556,0.0958651405963588,0.031022224179035,0.0350615812054503,0.156668699987267,0.00200707364520047
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20704.Liking for potato crisps,36556,0.00257089102452408,0.031001936333804,-0.0581929041897318,0.06333468623878,0.933911841638472
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20705.Liking for potatoes,36556,-0.0282300501849295,0.0315549331873989,-0.0900777192322313,0.0336176188623724,0.371010977940236
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20706.Liking for prawns,36556,-0.0194831810529043,0.0309748500852184,-0.0801938872199323,0.0412275251141237,0.529367128033193
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20707.Liking for raw carrots,36556,-0.00696727025776486,0.0307981158578091,-0.0673315773390706,0.0533970368235409,0.821033091367628
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20708.Liking for red meat,36556,-0.0248252809045013,0.0312611824826804,-0.0860971985705549,0.0364466367615523,0.427146481948861
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20709.Liking for red wine,36556,-0.232306057055418,0.031400377667535,-0.293850797283786,-0.170761316827049,1.52144527098252e-13
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,36556,0.0569049714260106,0.0312435371958862,-0.00433236147792641,0.118142304329948,0.068593413608644
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20711.Liking for roast chicken,36556,-0.0182398359762687,0.0320039243400055,-0.0809675276826795,0.0444878557301421,0.568744691073556
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20712.Liking for salad dressing,36556,-0.0166809117761019,0.0312006234694879,-0.0778341337762982,0.0444723102240944,0.592917977119879
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20713.Liking for salad leaves,36556,-0.00160840464806774,0.0312222493096243,-0.0628040132949313,0.0595872039987958,0.95891668726178
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20714.Liking for salami,36556,-0.0632821584471272,0.0309771029497569,-0.123997280228651,-0.00256703666560366,0.0410983460329938
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20715.Liking for salmon,36556,0.0192892605766021,0.0317480373432564,-0.0429368926161804,0.0815154137693846,0.543487858110712
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20716.Liking for salty foods,36556,-0.00167662363304852,0.0308408394302212,-0.0621246689162822,0.0587714216501851,0.956646727296013
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20717.Liking for salty pretzels,36556,-0.049569467112381,0.0308783751477701,-0.11009108240201,0.0109521481772484,0.108464601475063
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20718.Liking for sardines,36556,-0.0441449213148147,0.031040972082781,-0.104985226597065,0.016695383967436,0.155021929410909
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20719.Liking for sausages (meat),36556,-0.0119351017734963,0.0311902458556755,-0.0730679836506203,0.0491977801036278,0.701985859477112
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20720.Liking for savoury biscuits,36556,0.0386976237496096,0.0311165294612661,-0.0222907739944718,0.0996860214936911,0.213670391957566
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),36556,-0.0708535114204149,0.0309100739534651,-0.131437256369206,-0.0102697664716234,0.0219174332440057
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20722.Liking for skimmed milk,36556,-0.0224384961248501,0.0307766879118256,-0.0827608044320283,0.0378838121823282,0.465977621701799
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20723.Liking for smoked fish,36556,-0.0406274072287999,0.0312497621500769,-0.101876941042951,0.0206221265853509,0.193608882618958
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20724.Liking for soft cheese,36556,-0.0233026433764962,0.0309503021635236,-0.0839652356170024,0.0373599488640099,0.451529186420909
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20725.Liking for soy sauce,36556,-0.0709548259127625,0.031009957767896,-0.131734343137839,-0.0101753086876864,0.0221560656927719
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20726.Liking for soya milk,36556,0.0126881049209282,0.0309702083036889,-0.048013503354302,0.0733897131961584,0.682046297398092
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20727.Liking for spicy foods,36556,-0.101097528333334,0.031213067181248,-0.16227514000858,-0.0399199166580875,0.00120464151314669
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20728.Liking for spinach,36556,0.000864032260201524,0.0312255265088042,-0.0603379996970547,0.0620660642174578,0.977925485417747
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20729.Liking for spirits,36556,-0.193384665659513,0.0310872911099472,-0.25431575623501,-0.132453575084017,5.19989035056404e-10
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20730.Liking for strawberries,36556,-0.0247919041678343,0.0321321295301908,-0.0877708780470083,0.0381870697113396,0.440397307571231
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,36556,0.0295859138165177,0.0314347142705141,-0.0320261261536899,0.0911979537867253,0.346638144261439
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20732.Liking for sweet foods,36556,0.11933434556347,0.0312476145614231,0.0580890210230809,0.180579670103859,0.000135018479401421
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20733.Liking for taking the stairs,36556,-0.018096112196618,0.0315095986663453,-0.0798549255826548,0.0436627011894188,0.565777850064012
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20734.Liking for tea with sugar,36556,0.0251891415143278,0.0342196672374051,-0.0418814062709862,0.0922596892996418,0.461690778363875
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20735.Liking for tea without sugar,36556,-0.0163895627272009,0.0315713379778852,-0.0782693851638558,0.045490259709454,0.603686002112509
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20736.Liking for tomato ketchup,36556,0.0184516973554931,0.0308277489725167,-0.0419706906306396,0.0788740853416259,0.549495513922321
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20737.Liking for tinned tuna,36556,-0.00683176441316566,0.0312793342943787,-0.068139259630148,0.0544757308038167,0.827114161888555
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20738.Liking for turnip (white),36556,0.0085632222303626,0.0309575314782419,-0.0521135394669916,0.0692399839277168,0.782085304225161
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20739.Liking for vegetables,36556,0.013622542198162,0.032015764312842,-0.0491283558550084,0.0763734402513323,0.670487511250174
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20740.Liking for vinegar,36556,-0.0956069705132099,0.0309746740306982,-0.156317331613378,-0.0348966094130416,0.00203144678704471
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20741.Liking for watching television,36556,0.0331603401816282,0.0311982747435868,-0.027988278315802,0.0943089586790583,0.287864048793311
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20742.Liking for whisky,36556,-0.169736597088054,0.031227050473903,-0.230941616016904,-0.108531578159204,5.62435768607803e-08
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20743.Liking for white bread,36556,0.0046682840273581,0.0308678601609788,-0.0558327218881604,0.0651692899428766,0.879794609846203
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20744.Liking for white rice,36556,0.0342993484998263,0.0309290708837336,-0.0263216304322916,0.0949203274319441,0.267477564365645
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20745.Liking for white wine,36556,-0.129667010610556,0.0308929135559032,-0.190217121180126,-0.0691169000409854,2.73051485950202e-05
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,36556,0.0516778788177881,0.0312875741503823,-0.00964576651696127,0.113001524152537,0.0986339756395015
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20747.Liking for whole milk,36556,0.0684991579744161,0.0308946971396779,0.0079455515806474,0.129052764368185,0.0266388651944416
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20748.Liking for wholemeal bread,36556,-0.0244088331736526,0.0317948169825772,-0.086726674459504,0.0379090081121988,0.442689138723881
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20749.Liking for working up a sweat,36556,-0.0447811821723154,0.0310581876541719,-0.105655229974492,0.0160928656298615,0.149384695809766
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X21001.Body mass index (BMI),51964,-0.345208498708965,0.0224151849872152,-0.389142261283907,-0.301274736134023,2.96092701907459e-53
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X21002.Weight,51996,-0.0833232653380062,0.0108420398547103,-0.104573663453238,-0.0620728672227739,1.5874592163579e-14
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X21021.Pulse wave Arterial Stiffness index,36442,-0.0201936003547321,0.00830612250533086,-0.0364736004651806,-0.00391360024428357,0.0150723837922115
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,36318,-0.0418461589838936,0.0342170289065255,-0.108911535640684,0.0252192176728964,0.221381051091467
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,36320,-0.0785757781278113,0.0350038637029594,-0.147183350985612,-0.00996820527001091,0.0248108290467345
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,36321,-0.00685288517975465,0.0338698821679264,-0.0732378542288904,0.0595320838693811,0.839664267701104
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21040.Satisfaction with bowel habits,36294,-0.0108984518381198,0.0315722988579193,-0.0727801575996417,0.0509832539234021,0.729960745329663
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,36292,0.0347523657760063,0.0345032874924534,-0.0328740777092024,0.102378809261215,0.313861277491517
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21042.Greatest number of times bowels opened per day,36291,-0.0719817345864277,0.0340168407554961,-0.1386547424672,-0.00530872670565526,0.0343716066697848
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21043.Least number of times bowels opened per week,36256,-0.0636401506032385,0.034094540007805,-0.130465449018536,0.00318514781205938,0.0619986132762592
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21044.Average number of times bowels opened per day,36266,-0.0237993652160067,0.0371427627272675,-0.096599180161451,0.0490004497294376,0.521701846583337
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,36327,0.012703609351098,0.0343325594189537,-0.0545882071100512,0.0799954258122472,0.711380428052381
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,36323,-0.0120237472747506,0.0343251790867988,-0.0793010982848763,0.0552536037353751,0.726131054234516
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,36325,-0.0119352885555186,0.0393849671041111,-0.0891298240795764,0.0652592469685391,0.76186622126027
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,36325,-0.0267277329287858,0.0497640639886534,-0.124265298346546,0.0708098324889748,0.591221587598532
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,36325,-0.000173383198221012,0.04194293702696,-0.0823815397710626,0.0820347733746206,0.996701830744039
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,36324,-0.140162442992998,0.100832357179647,-0.337793863065107,0.0574689770791097,0.164552477083345
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,36327,0.013173542432233,0.0424208564238747,-0.0699713361585614,0.0963184210230275,0.756155681980185
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,36324,-0.106967997679574,0.039186443550526,-0.183773427038605,-0.0301625683205435,0.00635318964350054
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,36186,0.106851908010241,0.0390364824001826,0.0303404025058833,0.183363413514599,0.00621029941047669
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,36321,-0.0272415911478958,0.0352433052234137,-0.0963184693857867,0.0418352870899952,0.439570962046588
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,36326,-0.042076597296339,0.0594052039203787,-0.158510796980281,0.0743576023876032,0.478781483631852
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,36327,-0.0477283267016517,0.0342673965239867,-0.114892423888666,0.0194357704853623,0.163714204316292
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,36326,0.0758487304584297,0.0341548396150881,0.00890524481285702,0.142792216104002,0.0263980431443313
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X21100.Water hardness (USGS classification),51834,-0.00189419349499525,0.0191510032745267,-0.0394301599130676,0.0356417729230771,0.921211918951059
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2139.Age first had sexual intercourse,49046,0.0199866352933261,0.00443299299404202,0.0112979690250038,0.0286753015616485,6.56161496377657e-06
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2149.Lifetime number of sexual partners,47377,-0.094312944387591,0.0219060354162015,-0.137248773803346,-0.051377114971836,1.67574080105404e-05
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22032.IPAQ activity group,48238,-0.0064299610611007,0.0207115843854037,-0.0470246664564921,0.0341647443342906,0.756220247191537
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22033.Summed days activity,48635,-0.00862586134696196,0.0044242712484531,-0.01729743299393,4.57103000061215e-05,0.0512295996775994
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22034.Summed minutes activity,48238,-0.00754239337535872,0.00446737518225777,-0.016298448732584,0.00121366198186652,0.0913642135766595
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22037.MET minutes per week for walking,47517,-0.00843885589041954,0.00457353667305829,-0.0174029877696138,0.000525275988774717,0.0650315098309356
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22038.MET minutes per week for moderate activity,48238,-0.00801971931854026,0.00453717645197525,-0.0169125851644117,0.000873146527331222,0.0771504699877831
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22039.MET minutes per week for vigorous activity,48238,-0.0254545347174592,0.0207111866952186,-0.0660484606400877,0.0151393912051693,0.219077730434629
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22040.Summed MET minutes per week for all activity,47517,-0.00639622035008346,0.00452862422739674,-0.0152723238357811,0.00247988313561415,0.15784921981022
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X2217.Age started wearing glasses or contact lenses,48302,-0.00359475698274381,0.00458960630576803,-0.0125903853420492,0.00540087137656154,0.433496405216739
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X22501.Year ended full time education,34148,-0.00484694465563283,0.0203456644196796,-0.0447244469182048,0.0350305576069391,0.811711621661748
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X22506.Tobacco smoking,34110,0.0804217317335973,0.0777322835228524,-0.0719335439711934,0.232777007438388,0.30090170885208
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50633,-0.0846217541917349,0.0574124889496701,-0.197150232533088,0.0279067241496186,0.140515831891765
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23098.Weight,51559,-0.0808810735370158,0.010957065239019,-0.102356921405493,-0.0594052256685385,1.61674719026999e-13
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23099.Body fat percentage,51529,-0.145270240247234,0.00973205151567833,-0.164345061217963,-0.126195419276504,3.78475808686661e-50
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23100.Whole body fat mass,51486,-0.155904331396965,0.0097228988828092,-0.174961213207271,-0.136847449586659,1.50465538290381e-57
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23101.Whole body fat-free mass,51554,0.0136739253844589,0.00946124100794503,-0.00487010699111336,0.0322179577600311,0.148399345088378
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23102.Whole body water mass,51559,0.0138347133232594,0.00943687654062126,-0.00466156469635828,0.032330991342877,0.142654698220764
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23104.Body mass index (BMI),51559,-0.32824656761192,0.0222026356661891,-0.371763733517651,-0.284729401706189,3.1244382095193e-49
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23105.Basal metabolic rate,51559,0.00353718651002532,0.00983158325769755,-0.0157327166750619,0.0228070896951125,0.719016530396611
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23106.Impedance of whole body,51559,-0.0690977838030254,0.00773843990759641,-0.0842651260219144,-0.0539304415841364,4.60732520510012e-19
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23107.Impedance of leg (right),51559,-0.0773783887924371,0.00624184531260456,-0.0896124056051421,-0.0651443719797322,3.52861818056208e-35
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23108.Impedance of leg (left),51559,-0.0797795817986104,0.00622209870566715,-0.091974895261718,-0.0675842683355028,1.66142968756837e-37
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23109.Impedance of arm (right),51559,-0.000194187618328582,0.00766636817054199,-0.0152202692325909,0.0148318939959337,0.979792119958586
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23110.Impedance of arm (left),51559,-0.0106295164542773,0.00766046113600745,-0.0256440202808519,0.00438498737229725,0.165277893577574
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23111.Leg fat percentage (right),51559,-0.187479337125156,0.00990912388341854,-0.206901219936656,-0.168057454313656,3.13730712872715e-79
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23112.Leg fat mass (right),51559,-0.189642463927887,0.0106824695157886,-0.210580104178833,-0.168704823676941,4.83173219217504e-70
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23113.Leg fat-free mass (right),51558,0.0446974559233506,0.010409839746444,0.0242941700203202,0.0651007418263809,1.76385089006094e-05
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23114.Leg predicted mass (right),51558,0.0464053557251151,0.0104855736906337,0.0258536312914731,0.0669570801587572,9.66003029659651e-06
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23115.Leg fat percentage (left),51558,-0.204963692566729,0.0103436078681678,-0.225237163988338,-0.18469022114512,1.16080598025787e-86
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23116.Leg fat mass (left),51558,-0.207510461678853,0.0112965405932165,-0.229651681241557,-0.185369242116149,7.94497135605213e-75
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23117.Leg fat-free mass (left),51558,0.0309656982694489,0.0113272514709003,0.00876428538648423,0.0531671111524136,0.00626684889150865
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23118.Leg predicted mass (left),51558,0.0313592071493978,0.0114178277377764,0.00898026478335602,0.0537381495154395,0.00602795085813297
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23119.Arm fat percentage (right),51558,-0.0887142509768177,0.0109795916817534,-0.110234250673054,-0.0671942512805811,6.79765098806781e-16
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23120.Arm fat mass (right),51557,-0.104674079606406,0.0120008110921226,-0.128195669346967,-0.0811524898658462,2.90906850221376e-18
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23121.Arm fat-free mass (right),51556,-0.0273995743755107,0.0103739941884553,-0.0477326029848831,-0.00706654576613833,0.00826740400400395
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23122.Arm predicted mass (right),51556,-0.0281822066072336,0.0104215156097826,-0.0486083772024075,-0.00775603601205967,0.00685127133318823
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23123.Arm fat percentage (left),51554,-0.087813039396288,0.0103360478326241,-0.108071693148231,-0.0675543856443448,2.08343035196791e-17
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23124.Arm fat mass (left),51554,-0.120235203403593,0.01152833295809,-0.142830736001449,-0.0976396708057365,2.07170392954174e-25
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23125.Arm fat-free mass (left),51551,-0.015118403377146,0.0094558787066205,-0.0336519256421222,0.0034151188878302,0.109870716873339
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23126.Arm predicted mass (left),51550,-0.0171092104630725,0.00950871990277054,-0.0357463014725028,0.00152788054635775,0.0719815302449529
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23127.Trunk fat percentage,51548,-0.0979156619740434,0.0082592877987335,-0.114103866059561,-0.0817274578885258,2.51288326713684e-32
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23128.Trunk fat mass,51548,-0.121437815455686,0.00870442473201508,-0.138498487930435,-0.104377142980936,4.6781033190016e-44
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23129.Trunk fat-free mass,51547,0.00462132457948978,0.00820192660625631,-0.0114544515687726,0.0206971007277521,0.573138234080651
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23130.Trunk predicted mass,51545,0.00447764805124015,0.00819575043519047,-0.0115860228017332,0.0205413189042135,0.584839087181511
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23400.Total Cholesterol,42016,-0.185767384774004,0.00562455562959033,-0.196791513808001,-0.174743255740007,4.61138584708935e-230
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,42016,-0.197486215814598,0.00545743357645564,-0.208182785624451,-0.186789646004745,1.12220498430068e-273
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",42016,-0.181949158644707,0.00553313626901113,-0.192794105731968,-0.171104211557445,3.77721963813631e-228
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23403.VLDL Cholesterol,42016,-0.184718660038955,0.00571733858365032,-0.195924643662909,-0.173512676415,1.34066346217264e-220
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23404.Clinical LDL Cholesterol,42016,-0.196371283162457,0.00544491672902817,-0.207043319951352,-0.185699246373562,6.1629256631484e-272
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23405.LDL Cholesterol,42016,-0.203982027407293,0.00539760579503393,-0.21456133476556,-0.193402720049027,4.40045133690514e-297
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23406.HDL Cholesterol,42016,-0.0167603861973077,0.00646283377984274,-0.0294275404057995,-0.00409323198881597,0.00951493623954987
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23407.Total Triglycerides,42016,-0.125563297206564,0.0059383857080859,-0.137202533194412,-0.113924061218716,1.20923711245857e-97
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23408.Triglycerides in VLDL,42016,-0.128854139360649,0.00602596416365057,-0.140665029121405,-0.117043249599894,8.79798873765171e-100
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23409.Triglycerides in LDL,42016,-0.134121602289353,0.00556567177551676,-0.145030318969366,-0.12321288560934,1.20455212679852e-125
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23410.Triglycerides in HDL,42016,-0.0556521885314933,0.0058902147107266,-0.0671970093645174,-0.0441073676984691,4.00779888234192e-21
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,42016,-0.157139860916183,0.00572149391357725,-0.168353988986794,-0.145925732845571,1.30546584276867e-161
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23412.Phospholipids in VLDL,42016,-0.170918060089919,0.00581611259636281,-0.18231764077879,-0.159518479401048,5.10475661323455e-184
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23413.Phospholipids in LDL,42016,-0.206043016258936,0.00541198132353539,-0.216650499653065,-0.195435532864807,2.93973537795595e-301
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23414.Phospholipids in HDL,42016,-0.00807527091206773,0.00619153165476474,-0.0202106729554066,0.00406013113127116,0.19217261738766
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23415.Total Esterified Cholesterol,42016,-0.184708183672492,0.00565889560789734,-0.195799619063971,-0.173616748281013,6.08808419157524e-225
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,42016,-0.181408235036973,0.00568995746515599,-0.192560551668679,-0.170255918405268,4.48132106387751e-215
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,42016,-0.208227442368006,0.00538606078449592,-0.218784121505618,-0.197670763230394,1.67926999715508e-308
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,42016,-0.0136747511152081,0.00646911071381092,-0.0263542081142775,-0.000995294116138667,0.0345462021549685
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23419.Total Free Cholesterol,42016,-0.185469280300817,0.00555253320238785,-0.196352245377497,-0.174586315224137,4.6199626412763e-235
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23420.Free Cholesterol in VLDL,42016,-0.182580975171328,0.005765592639881,-0.193881536745495,-0.171280413597161,2.57825374544891e-212
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23421.Free Cholesterol in LDL,42016,-0.186360194744751,0.00547207733728098,-0.197085466325822,-0.17563492316368,6.70851938780253e-244
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23422.Free Cholesterol in HDL,42016,-0.0252464834426474,0.00642418768043717,-0.0378378912963043,-0.0126550755889906,8.54037749261777e-05
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,42016,-0.181293593387819,0.00543381429122329,-0.191943869398617,-0.170643317377021,1.52347623206114e-234
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23424.Total Lipids in VLDL,42016,-0.159826208482593,0.00584722277080605,-0.171286765113373,-0.148365651851813,3.93964428164272e-160
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23425.Total Lipids in LDL,42016,-0.206667001370434,0.00539109956449798,-0.21723355651685,-0.196100446224018,3.36554133697326e-305
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23426.Total Lipids in HDL,42016,-0.01702573035852,0.0062912486522191,-0.0293565777168694,-0.00469488300017054,0.00681325812743297
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,42016,-0.133291259116672,0.00586675151529594,-0.144790092086652,-0.121792426146692,3.68683479221532e-112
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23428.Concentration of VLDL Particles,42016,-0.17459398478682,0.00572799319306301,-0.185820851445224,-0.163367118128417,2.31017028569436e-197
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23429.Concentration of LDL Particles,42016,-0.197972056181733,0.00544872483599562,-0.208651556860285,-0.187292555503182,8.7125710960187e-276
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23430.Concentration of HDL Particles,42016,-0.105981681735738,0.0059129958476972,-0.117571153597225,-0.0943922098742515,5.19193318541916e-71
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,42016,-0.110627083172319,0.00615076245937548,-0.122682577592695,-0.0985715887519431,1.73274405137804e-71
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23432.Average Diameter for LDL Particles,42016,-0.00767314097361382,0.00587889787524979,-0.0191957808091034,0.00384949886187577,0.191846937524755
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23433.Average Diameter for HDL Particles,42016,0.132985494837675,0.00638971104020565,0.120461661198872,0.145509328476478,1.03994713794305e-94
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23434.Phosphoglycerides,42008,-0.129843279900388,0.00578586724404961,-0.141183579698725,-0.11850298010205,1.59360405239251e-109
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,42008,-0.0823816106675842,0.006315803502234,-0.0947605855319629,-0.0700026358032056,1.18583638090001e-38
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23436.Total Cholines,42008,-0.138714230541807,0.00587147441774561,-0.150222320400588,-0.127206140683025,6.18815883866577e-121
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23437.Phosphatidylcholines,42008,-0.126911872175424,0.00591487539741913,-0.138505027954365,-0.115318716396482,1.92849686524007e-100
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23438.Sphingomyelins,42008,-0.15765051826817,0.00588698652916742,-0.169189011865338,-0.146112024671002,6.04466074590037e-154
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23439.Apolipoprotein B,42016,-0.194123704710005,0.00547972807943279,-0.204863971745693,-0.183383437674316,7.21039819435178e-263
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23440.Apolipoprotein A1,42016,-0.0505935776699324,0.00614514411685175,-0.0626380601389618,-0.0385490952009029,1.99180535259364e-16
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,42016,-0.15078205627764,0.00570356093804733,-0.161961035716212,-0.139603076839067,3.5436698140163e-150
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23442.Total Fatty Acids,42008,-0.145036083665906,0.00537090282241284,-0.155563053197835,-0.134509114133977,1.94834146585757e-156
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23443.Degree of Unsaturation,42008,0.0214673049915385,0.00596174794268837,0.00978227902386932,0.0331523309592077,0.000318335224562399
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23444.Omega-3 Fatty Acids,42008,-0.0791193669347394,0.00575804068220647,-0.0904051266718641,-0.0678336071976147,1.12703338879123e-42
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23445.Omega-6 Fatty Acids,42008,-0.149337983627787,0.00555724144419843,-0.160230176858416,-0.138445790397159,5.61772669733468e-155
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,42008,-0.148052360767802,0.00558732986106663,-0.159003527295492,-0.137101194240111,7.58612651120284e-151
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,42008,-0.121665437971378,0.00552072296956024,-0.132486054991716,-0.11084482095104,9.30116190946021e-106
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23448.Saturated Fatty Acids,42008,-0.147039925289756,0.00528999499925926,-0.157408315488304,-0.136671535091208,2.26586789110229e-165
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23449.Linoleic Acid,42008,-0.132903785415733,0.00557853757587838,-0.143837719064454,-0.121969851767011,6.60896049997555e-123
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23450.Docosahexaenoic Acid,42008,-0.0717789513752733,0.00571264400073566,-0.0829757336167152,-0.0605821691338314,5.25092093314671e-36
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,42008,-0.00513415129838267,0.00581424414173354,-0.0165300698161804,0.00626176721941507,0.377235959930987
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,42008,0.0764461917174072,0.005672424150836,0.0653282403817686,0.0875641430530457,3.96636576138711e-41
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,42008,0.077375293270809,0.00580612388857962,0.065995290449193,0.0887552960924251,2.92719935388143e-40
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,42008,-0.0363010197992732,0.00612462303332484,-0.0483052809445899,-0.0242967586539565,3.15977354631095e-09
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,42008,-0.0863636895837724,0.00526864431420639,-0.0966902324396169,-0.0760371467279279,8.31571136205496e-60
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,42008,0.0254521767707686,0.00584695079259955,0.0139921532172735,0.0369122003242638,1.35239896396809e-05
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,42008,0.018637101445865,0.00568553559094352,0.00749345168761566,0.0297807512041143,0.00104816968987035
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,42008,0.0581949828682587,0.00605465742983302,0.046327854305786,0.0700621114307315,8.39719855836902e-22
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,42008,0.024764095495054,0.00573842043005545,0.0135167914521453,0.0360113995379627,1.60390751767696e-05
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23460.Alanine,42014,0.024517145707667,0.00573038606682765,0.0132855890166848,0.0357487023986492,1.89507523689497e-05
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23461.Glutamine,41981,0.0476207813549707,0.00563828055281675,0.0365697514714499,0.0586718112384915,3.32353747774579e-17
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23462.Glycine,42002,0.0860003579410295,0.00678773949912412,0.0726963885227462,0.0993043273593128,1.40613325704006e-36
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23463.Histidine,42000,0.0140838475731112,0.00566707201392044,0.00297638642582712,0.0251913087203952,0.0129597135469051
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),42006,0.0522512112431277,0.00635139671708508,0.0398024736776409,0.0646999488086144,2.10018288536359e-16
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23465.Isoleucine,42014,0.0928636703043323,0.00608735514774277,0.0809324542147565,0.104794886393908,4.16078170733769e-52
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23466.Leucine,42014,0.0358055263191167,0.00630665600353239,0.0234444805521932,0.0481665720860402,1.39577160434745e-08
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23467.Valine,42006,0.0417277549706443,0.00631557669994194,0.0293492246387581,0.0541062853025305,4.06675646802221e-11
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23468.Phenylalanine,42009,0.0947925265078912,0.00578943940663435,0.0834452252708879,0.106139827744895,1.12334181553375e-59
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23469.Tyrosine,42003,0.0584428475043338,0.00604105761719297,0.0466023745746356,0.0702833204340321,4.57907642333446e-22
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23470.Glucose,41995,-0.000463646989362246,0.00552638691283411,-0.0112953653385171,0.0103680713597926,0.933139620736935
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23471.Lactate,41996,-0.0368769146892654,0.00580536442587509,-0.0482554289639806,-0.0254984004145502,2.19098812830167e-10
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23472.Pyruvate,41980,-0.00120858859080788,0.00559172733220562,-0.0121683741619309,0.00975119698031513,0.828882941128658
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23473.Citrate,42014,0.026588585999113,0.00576843107734077,0.0152824610875251,0.0378947109107009,4.07700435868081e-06
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23474.3-Hydroxybutyrate,41736,-0.0886393068667005,0.00633397679600236,-0.101053901386865,-0.0762247123465359,3.50699555300578e-44
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23475.Acetate,42004,0.0353403323224007,0.0055103815910111,0.0245399844040189,0.0461406802407824,1.47076049469768e-10
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23476.Acetoacetate,42015,-0.00905905114536907,0.00579697965091494,-0.0204211312611624,0.00230302897042421,0.118142254932665
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23477.Acetone,42015,0.00239437232211536,0.00574825676322455,-0.00887221093380477,0.0136609555780355,0.677022401640927
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23478.Creatinine,41763,0.0440192206713734,0.00692071398779014,0.0304546212553048,0.0575838200874421,2.07745634175291e-10
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23479.Albumin,42015,-0.0648148822408831,0.00569622857470503,-0.075979490247305,-0.0536502742344613,7.32878654496781e-30
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23480.Glycoprotein Acetyls,42016,-0.0484715140517939,0.00596094048377855,-0.0601549573999999,-0.036788070703588,4.60922210827738e-16
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,42016,-0.0841376313563934,0.00602142797678783,-0.0959396301908976,-0.0723356325218893,4.63504430983901e-44
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,42016,-0.0841005069096701,0.0059852030646747,-0.0958315049164325,-0.0723695089029077,1.56192726559978e-44
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,42016,-0.0856641280313322,0.00618776627677011,-0.0977921499338016,-0.0735361061288628,2.73948900274615e-43
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,42016,-0.108387307809287,0.00606125599694611,-0.120267369563302,-0.0965072460552731,1.07562985391555e-70
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,42016,-0.121838607439063,0.0060428741950013,-0.133682640861266,-0.10999457401686,4.35456912021883e-89
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,42016,-0.0886640230041695,0.00604091995312186,-0.100504226112288,-0.0768238198960506,2.13891362502264e-48
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,42016,-0.0711196832149955,0.00587812936374782,-0.0826408167679413,-0.0595985496620498,1.59714045438683e-33
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,42016,-0.143961560855406,0.00620201129023131,-0.156117502984259,-0.131805618726552,6.81175273214703e-117
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,42016,-0.141075228652209,0.00616064745446815,-0.153150097662967,-0.129000359641452,7.08348443307692e-114
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,42016,-0.143385539183229,0.00615274015869192,-0.155444909894265,-0.131326168472193,8.62580533823086e-118
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,42016,-0.17323185820468,0.00605840768563529,-0.185106337268525,-0.161357379140835,1.31495166991765e-174
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,42016,-0.191956591276691,0.00600836063210007,-0.203732978115607,-0.180180204437775,6.30128785971352e-216
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,42016,-0.147470335866284,0.00609289036200872,-0.159412400975822,-0.135528270756747,1.03966443157158e-126
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,42016,-0.124977867859409,0.00620222317956549,-0.137134225291357,-0.11282151042746,5.49548295333238e-89
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,42016,-0.154742341492935,0.00609128245147009,-0.166681255097816,-0.142803427888054,4.31554886441736e-139
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23496.Total Lipids in Large VLDL,42016,-0.155907471550826,0.0060716987594585,-0.167808001119365,-0.144006941982288,5.42042850608698e-142
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23497.Phospholipids in Large VLDL,42016,-0.156580234176982,0.00619182434600894,-0.16871620989516,-0.144444258458805,7.11356228758185e-138
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23498.Cholesterol in Large VLDL,42016,-0.174694427837758,0.00608213877966362,-0.186615419845898,-0.162773435829617,4.02974388568686e-176
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,42016,-0.176542398401149,0.00603017495346165,-0.188361541309934,-0.164723255492364,1.07708428213598e-182
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,42016,-0.169147011710146,0.00615272049338846,-0.181206343877188,-0.157087679543105,6.53113680132429e-162
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23501.Triglycerides in Large VLDL,42016,-0.141427368152574,0.00601266160459758,-0.153212184897586,-0.129642551407563,6.45073486557075e-120
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,42016,-0.196054328325261,0.00562134321316271,-0.20707216102306,-0.185036495627463,3.45607208333476e-255
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,42016,-0.188076875590887,0.00566216421143107,-0.199174717445292,-0.176979033736482,1.42856513132863e-232
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,42016,-0.1932241582476,0.00561166128909444,-0.204223014374225,-0.182225302120975,4.77799270245708e-249
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,42016,-0.179007087552022,0.00553484090762547,-0.189855375730968,-0.168158799373076,4.92478443246241e-221
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,42016,-0.158766685723258,0.0055628273365329,-0.169669827302863,-0.147863544143654,5.48661384293044e-174
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,42016,-0.192804769531543,0.00557993036950177,-0.203741433055767,-0.18186810600732,1.04183754338312e-250
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,42016,-0.156290622651841,0.00590749713657744,-0.167869317039533,-0.144711928264149,2.15055048113536e-150
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,42016,-0.170663404569275,0.00588383300317005,-0.182195717255489,-0.159131091883062,1.82714676987107e-179
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23510.Total Lipids in Small VLDL,42016,-0.177797076671425,0.00587268036299611,-0.189307530182897,-0.166286623159953,8.00950285409651e-195
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23511.Phospholipids in Small VLDL,42016,-0.195904906280093,0.00569970221218641,-0.207076322615979,-0.184733489944208,3.34808100086618e-248
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23512.Cholesterol in Small VLDL,42016,-0.197213701678616,0.00574823084617493,-0.208480234137119,-0.185947169220113,2.41059835168594e-247
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,42016,-0.194584391930282,0.00586690659931973,-0.206083528864949,-0.183085254995615,6.62884115711288e-232
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,42016,-0.197302074699565,0.00557486092835312,-0.208228802119138,-0.186375347279993,2.19865222860313e-262
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23515.Triglycerides in Small VLDL,42016,-0.112933389286145,0.00604883433070021,-0.124789104574318,-0.101077673997973,8.10507885660182e-77
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,42016,-0.13887566670604,0.0056675347826156,-0.149984034879966,-0.127767298532113,9.39069912601008e-130
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,42016,-0.131404106260735,0.00572332487266679,-0.142621823011162,-0.120186389510308,1.88084869943497e-114
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,42016,-0.124195304491801,0.00571661958925292,-0.135399878886737,-0.112990730096865,6.95261599680974e-103
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,42016,-0.127117432929646,0.00576366058253925,-0.138414207671423,-0.115820658187869,6.45329504773806e-106
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,42016,-0.119410772389821,0.00581649763738824,-0.130811107759102,-0.10801043702054,3.04040831671893e-92
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,42016,-0.139575977011991,0.00569468692451092,-0.150737563384032,-0.12841439063995,8.12859648069386e-130
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,42016,-0.0944213876804594,0.0058879592304474,-0.105961787772136,-0.0828809875887825,2.42751732069248e-57
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23523.Concentration of IDL Particles,42016,-0.157001414083114,0.00557155385881835,-0.167921659646398,-0.14608116851983,8.82183579870203e-170
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23524.Total Lipids in IDL,42016,-0.160279145784057,0.00569004850551924,-0.171431640854875,-0.149126650713239,1.17558537120251e-169
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23525.Phospholipids in IDL,42016,-0.154532246678391,0.00569963868914128,-0.165703538509108,-0.143360954847674,1.18986839057296e-157
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23526.Cholesterol in IDL,42016,-0.155428557204742,0.0057297226510893,-0.166658813600877,-0.144198300808607,8.28150766038767e-158
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,42016,-0.154433567911766,0.00573981911912971,-0.165683613385261,-0.143183522438272,2.40653241717484e-155
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23528.Free Cholesterol in IDL,42016,-0.153702955100536,0.00569171090941661,-0.164858708482992,-0.142547201718079,1.90508697650151e-156
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23529.Triglycerides in IDL,42016,-0.102658294781851,0.00567250988399126,-0.113776414154474,-0.0915401754092285,2.41240789045128e-72
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23530.Concentration of Large LDL Particles,42016,-0.185952178471696,0.00545328457983961,-0.196640616248181,-0.17526374069521,1.76463712937205e-244
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23531.Total Lipids in Large LDL,42016,-0.197028166491012,0.00544443715182788,-0.207699263308595,-0.186357069673429,1.04192639905556e-273
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23532.Phospholipids in Large LDL,42016,-0.197125472862955,0.00546227334498607,-0.207831528619127,-0.186419417106782,2.84618633221017e-272
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23533.Cholesterol in Large LDL,42016,-0.193267502067449,0.00545735397359479,-0.203963915855695,-0.182571088279203,1.05192137334993e-262
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,42016,-0.196828885190404,0.00543997316784968,-0.207491232599389,-0.186166537781418,1.30987086446207e-273
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,42016,-0.179795216080179,0.00553978367847189,-0.190653192089984,-0.168937240070374,1.62564637748714e-222
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23536.Triglycerides in Large LDL,42016,-0.132408297226212,0.00555924399708311,-0.143304415460495,-0.12151217899193,7.63394885943189e-123
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,42016,-0.209342883558357,0.00545715576549438,-0.220038908858726,-0.198646858257988,1.35443947231027e-305
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23538.Total Lipids in Medium LDL,42016,-0.221938177198616,0.0053794803660608,-0.232481958716095,-0.211394395681137,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23539.Phospholipids in Medium LDL,42016,-0.219655891748919,0.00540787669092545,-0.230255330063133,-0.209056453434705,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23540.Cholesterol in Medium LDL,42016,-0.221071076436238,0.00537372312088794,-0.231603573753178,-0.210538579119298,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,42016,-0.224225294928975,0.00538959447928976,-0.234788900108383,-0.213661689749567,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,42016,-0.199341466145363,0.00540180802481263,-0.209929009873995,-0.18875392241673,5.08462081564819e-284
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23543.Triglycerides in Medium LDL,42016,-0.141521784111722,0.00558409029335277,-0.152466601086693,-0.13057696713675,1.85577627826948e-138
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23544.Concentration of Small LDL Particles,42016,-0.195660829224524,0.0054993546028945,-0.206439564246198,-0.184882094202851,4.99685567956633e-265
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23545.Total Lipids in Small LDL,42016,-0.208764999840547,0.00537550521797743,-0.219300990067783,-0.198229009613311,1.66882806914625e-308
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23546.Phospholipids in Small LDL,42016,-0.191613996797485,0.00540285001108966,-0.202203582819221,-0.18102441077575,1.99814617696752e-263
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23547.Cholesterol in Small LDL,42016,-0.212514924253557,0.00538154267930361,-0.223062747904992,-0.201967100602122,1.66880539388041e-308
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,42016,-0.21517627743166,0.00537850146814095,-0.225718140309216,-0.204634414554103,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,42016,-0.183666046585167,0.00545459689927076,-0.194357056507737,-0.172975036662596,1.10790844554354e-238
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23550.Triglycerides in Small LDL,42016,-0.118206649566884,0.00569867480070242,-0.12937605217626,-0.107037246957507,4.23621854836842e-94
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,42016,0.0523289446183848,0.00659147889603788,0.0394096459821506,0.065248243254619,2.20154387128726e-15
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,42016,0.0989726283466125,0.0065754089914279,0.0860848267234138,0.111860429969811,8.70612732777563e-51
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,42016,0.126624014485146,0.00650802595379496,0.113868283615707,0.139379745354584,3.57368306424054e-83
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,42016,0.0720400299587949,0.00668176251857538,0.0589437754223872,0.0851362844952027,5.4251014367054e-27
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,42016,0.066440359912998,0.00671907558433966,0.0532709717676923,0.0796097480583038,5.60591830756129e-23
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,42016,0.0843890837207444,0.00649102442392192,0.0716666758498574,0.0971114915916314,2.06312441752557e-38
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,42016,-0.0412387007856144,0.00551351038736146,-0.0520451811448429,-0.030432220426386,7.91932883598347e-14
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23558.Concentration of Large HDL Particles,42016,0.0684732969009982,0.00663335472505959,0.0554719216398814,0.081474672162115,6.90303057509668e-25
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23559.Total Lipids in Large HDL,42016,0.0857365213280698,0.00655954021733222,0.0728798225020987,0.098593220154041,8.37630877217177e-39
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23560.Phospholipids in Large HDL,42016,0.0904628893168449,0.00648905243254832,0.0777443465490502,0.10318143208464,7.23351380025866e-44
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23561.Cholesterol in Large HDL,42016,0.080880346937054,0.00667180699984267,0.0678036052173623,0.0939570886567456,1.20048461018343e-33
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,42016,0.0806266519896009,0.00669602946037886,0.0675024342472584,0.0937508697319435,3.21000921551541e-33
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,42016,0.0806948981177464,0.00659180161700106,0.0677749669484243,0.0936148292870685,2.83470940849553e-34
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23564.Triglycerides in Large HDL,42016,0.018564813731446,0.00581511551086416,0.00716718733015221,0.0299624401327397,0.00141367505259976
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,42016,-0.0320977694624926,0.00608822249883751,-0.0440306855602141,-0.0201648533647711,1.36957903488338e-07
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23566.Total Lipids in Medium HDL,42016,-0.0285061585728396,0.00598867216124101,-0.040243956008872,-0.0167683611368072,1.95601232361165e-06
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23567.Phospholipids in Medium HDL,42016,-0.0239220928985981,0.00588958115186798,-0.0354656719562593,-0.0123785138409369,4.89800762707881e-05
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23568.Cholesterol in Medium HDL,42016,-0.0255006725049586,0.00615993281522062,-0.037574140822791,-0.0134272041871261,3.4978733513867e-05
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,42016,-0.0230079224060869,0.00615258335512988,-0.0350669857821415,-0.0109488590300323,0.000185113271538625
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,42016,-0.0351455140433407,0.00618341252612197,-0.0472650025945398,-0.0230260254921417,1.34447092980142e-08
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23571.Triglycerides in Medium HDL,42016,-0.0504513983700357,0.00595812755942387,-0.0621293283865065,-0.0387734683535649,2.76181116142513e-17
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23572.Concentration of Small HDL Particles,42016,-0.184909223311106,0.00549209626704856,-0.195673731994521,-0.174144714627691,1.23710058157478e-238
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23573.Total Lipids in Small HDL,42016,-0.156451648775139,0.00555401264156424,-0.167337513552605,-0.145565783997673,1.15101354525848e-169
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23574.Phospholipids in Small HDL,42016,-0.130856572327073,0.0055713136371448,-0.141776347055877,-0.119936797598269,1.39265214827469e-119
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23575.Cholesterol in Small HDL,42016,-0.172693066117266,0.00548981887146124,-0.18345311110533,-0.161933021129202,1.25396015809461e-209
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,42016,-0.168395388981586,0.00553579723274685,-0.179245551557769,-0.157545226405402,1.33306484956669e-196
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,42016,-0.164496821312318,0.00548809429840687,-0.175253486137196,-0.153740156487441,4.04593478078202e-191
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23578.Triglycerides in Small HDL,42016,-0.115850520337755,0.00635463729071521,-0.128305609427557,-0.103395431247954,2.25230803877436e-73
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41636,0.0358087180138787,0.0064353959804925,0.0231953418921134,0.048422094135644,2.68338378505998e-08
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41636,-0.0255256117582216,0.00618146871478127,-0.0376412904391929,-0.0134099330772503,3.66014920644586e-05
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41636,-0.0580030290036825,0.00624481245099299,-0.0702428614076288,-0.0457631965997362,1.81485516020882e-20
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41636,0.0348698943209163,0.00617814693952082,0.0227607263194555,0.0469790623223771,1.69538904289419e-08
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41636,0.0147117980867809,0.00625860414990537,0.00244493395296633,0.0269786622205954,0.0187553862032904
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,41943,-0.0691535891047944,0.0062878894019464,-0.0814778523326093,-0.0568293258769794,5.15941421359968e-28
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,41943,-0.0097270719083662,0.00636988933947942,-0.0222120550137459,0.00275791119701347,0.126774920622104
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,41943,-0.0134543641783521,0.00632943418131667,-0.0258600551737328,-0.00104867318297147,0.0335480626805091
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,41943,0.0025477903185129,0.00639324670401049,-0.00998297322134766,0.0150785538583735,0.690258639239847
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,41943,0.0283852121549015,0.00634445917471343,0.0159500721724632,0.0408203521373398,7.73988090473568e-06
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,42016,-0.0844931029330138,0.00656325420332093,-0.0973570811715228,-0.0716291246945048,1.05859385374774e-37
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,42016,-0.0188873064480291,0.00616432628199086,-0.0309693859607311,-0.00680522693532699,0.00218854585527193
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,42016,0.000745299917094089,0.0062656923622238,-0.0115354571128646,0.0130260569470527,0.905317279297773
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,42016,-0.0669010442382036,0.00623053554496092,-0.079112893906327,-0.0546891945700802,8.70779264450141e-27
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,42016,0.0504200373292813,0.00627584188395306,0.0381193872367333,0.0627206874218293,1.02189283014245e-15
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,42016,-0.0855901010589222,0.00599716029581043,-0.0973445352387106,-0.0738356668791337,7.10731925093634e-46
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,42016,-0.0393903184909678,0.0062459703479201,-0.0516324203728912,-0.0271482166090444,2.94335564777614e-10
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,42016,-0.0288288049460898,0.00629127343138697,-0.0411597008716082,-0.0164979090205713,4.63929313467538e-06
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,42016,-0.0667154662502317,0.0060923986232799,-0.0786565675518603,-0.0547743649486031,8.65318261060377e-28
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,42016,0.0503124451258301,0.00618739223383294,0.0381851563475175,0.0624397339041426,4.61207403703686e-16
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,42016,-0.0899732758683708,0.00604155372090313,-0.101814721161341,-0.0781318305754007,9.2170696354803e-50
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,42016,-0.08423109040922,0.0058384625965561,-0.09567447709847,-0.0727877037199701,7.84907240495064e-47
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,42016,-0.0746316503089726,0.00576286682409896,-0.0859268692842066,-0.0633364313337387,3.95320924706594e-38
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,42016,-0.0914462215236109,0.0060933646065246,-0.103389216152399,-0.0795032268948227,1.68368160461751e-50
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,42016,0.0869215464814852,0.00589434807865397,0.0753686242473235,0.098474468715647,7.80030502285184e-49
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,42016,0.0364123455783427,0.00575869111552118,0.0251253109919212,0.0476993801647643,2.64621047048022e-10
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,42016,-0.0355290427677197,0.00607313240592747,-0.0474323822833376,-0.0236257032521019,5.02428613224219e-09
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,42016,-0.0238218824302258,0.00615986967786127,-0.0358952269988339,-0.0117485378616177,0.000110579929823183
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,42016,-0.0964276583966995,0.00531041879145686,-0.106836079227955,-0.086019237565444,8.2154591163103e-73
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,42016,0.0302525733732569,0.00600089422571515,0.0184908206908552,0.0420143260556586,4.68300137370919e-07
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,42016,0.0875439836901771,0.00558408368441296,0.0765991796687277,0.0984887877116265,6.62389257878286e-55
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,42016,-0.0730797846018434,0.00587332700138537,-0.0845915055245587,-0.0615680636791281,2.40205514460575e-35
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,42016,-0.0610471794284719,0.00580274764237124,-0.0724205648075196,-0.0496737940494243,8.76751584900728e-26
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,42016,-0.0414433627941933,0.00541568436976575,-0.0520581041589342,-0.0308286214294524,2.10580758130537e-14
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,42016,0.0582278029948578,0.0059305760699091,0.046603873897836,0.0698517320918797,1.12044846529929e-22
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,42016,0.0525324357638837,0.00575856582689689,0.0412456467431658,0.0638192247846016,8.37470138731314e-20
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,42016,-0.101064037004101,0.00582163989527144,-0.112474451198833,-0.0896536228093689,8.87009286665463e-67
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,42016,-0.117301641052593,0.00554422991488366,-0.128168331685765,-0.106434950419421,9.24681811787036e-98
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,42016,-0.0100005901502342,0.00630603027206031,-0.0223604094834724,0.002359229183004,0.112790718049811
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,42016,0.0769887853310524,0.00575892441568882,0.0657012934763023,0.0882762771858024,1.6752263817814e-40
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,42016,0.102652157029717,0.00586070788292519,0.0911651695791837,0.11413914448025,6.22986838108675e-68
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,42016,-0.130159174672614,0.00575776614197419,-0.141444396310884,-0.118873953034345,4.45354065448584e-111
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,42016,-0.143667042899656,0.00580658717464549,-0.155047953761961,-0.132286132037351,3.38801579706249e-132
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,42016,0.0368793927369648,0.00608820604366118,0.0249465088913888,0.0488122765825407,1.41938776265297e-09
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,42016,0.090274012293022,0.00572933888064888,0.0790445080869502,0.101503516499094,1.94662624703817e-55
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,42016,0.142475153772489,0.00578325056473442,0.131139982665609,0.153810324879368,4.18309485739957e-131
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,42016,-0.150323158874217,0.00560343776554515,-0.161305896894685,-0.139340420853748,1.79455051322767e-154
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,42016,-0.147825497145337,0.00571740501393932,-0.159031610972658,-0.136619383318016,6.87655956107825e-144
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,42016,-0.000809483794145414,0.00579611179249124,-0.0121698629074283,0.0105508953191374,0.888930889076187
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,42016,0.0420476138892545,0.00588794061758937,0.0305072502787794,0.0535879774997297,9.72065468917425e-13
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,42003,0.183477336351935,0.00609359609136523,0.17153388801286,0.195420784691011,8.76717396806969e-193
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,42003,-0.125106933852422,0.00535776892162845,-0.135608160938813,-0.11460570676603,3.06992140465376e-118
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,42003,-0.113149795501403,0.00500166201203873,-0.122953053044999,-0.103346537957807,3.11444290896899e-111
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,42003,-0.0868433650722584,0.00646951444675097,-0.0995236133878903,-0.0741631167566265,8.08313776539619e-41
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,42003,-0.107810979909789,0.00608194789249656,-0.119731597779082,-0.0958903620404954,1.62726349013715e-69
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,42016,0.0147173451905338,0.00579624124817312,0.00335671234411444,0.0260779780369531,0.0111244029706915
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,42016,0.030992441221952,0.00612968694675156,0.0189782548063189,0.043006627637585,4.33511274664958e-07
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,42016,0.01990196599205,0.0059011223747353,0.00833576613756879,0.0314681658465312,0.000746798301949153
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,42016,0.0329108727638984,0.00585799008122987,0.0214292122046879,0.044392533323109,1.96889821545917e-08
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,42016,-0.0520428588938979,0.00587351829526764,-0.0635549547526224,-0.0405307630351733,8.94961923827436e-19
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,42016,0.0426427765097836,0.00626992824920018,0.0303537171413512,0.054931835878216,1.08176869372342e-11
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,42016,0.00485670231265192,0.00627213580225768,-0.00743668385977312,0.017150088485077,0.438749369422154
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,42016,0.0139266954377347,0.00596290691746849,0.00223939787949649,0.0256139929959729,0.0195291188085524
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,42016,-0.0427040768335871,0.00650689731265007,-0.0554575955663812,-0.0299505581007929,5.47123895600367e-11
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,42016,-0.0367442061355303,0.00617641832529821,-0.0488499860531148,-0.0246384262179458,2.76315758907467e-09
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,42016,0.135082513498116,0.00561575610492147,0.12407563153247,0.146089395463762,3.31651343235023e-125
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,42016,-0.0654160426844508,0.00566301928146184,-0.076515560476116,-0.0543165248927856,1.01431579910654e-30
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,42016,-0.0533689812218855,0.00559306049884811,-0.0643313797996278,-0.0424065826441432,1.63946108196628e-21
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,42016,-0.0684603690708729,0.00605149263468596,-0.0803212946348573,-0.0565994435068884,1.54020824008782e-29
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,42016,-0.0397157888891103,0.00642416606329614,-0.0523071543731707,-0.0271244234050499,6.50270079719829e-10
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51761,0.00415610083506644,0.00485968941235896,-0.00536889041315712,0.01368109208329,0.392438525168747
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51761,0.0064098783945877,0.00472035806787519,-0.00284202341844766,0.0156617802076231,0.174501642135802
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50222,0.0042487729217576,0.00450414524047887,-0.00457935174958099,0.0130768975930962,0.345536571919239
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50222,0.00811921310090804,0.00490865432838567,-0.00150174938272787,0.0177401755845439,0.0981296590203501
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50222,0.00375193503048118,0.00486315300319601,-0.00577984485578299,0.0132837149167454,0.440417532027583
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50222,-0.00218352894534495,0.00446942367229419,-0.0109435993430416,0.00657654145235166,0.625166539541626
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24009.Traffic intensity on the nearest road,51761,-0.00466355716620264,0.0411748116303236,-0.0853661879616368,0.0760390736292316,0.909823523277383
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24010.Inverse distance to the nearest road,51761,-0.00283157717615068,0.00424671902315852,-0.0111551464615414,0.00549199210924002,0.504926853444901
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24011.Traffic intensity on the nearest major road,51761,0.000598834881147438,0.00423264236844712,-0.00769714416100891,0.00889481392330379,0.887491870054052
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24012.Inverse distance to the nearest major road,51761,0.00340699182492457,0.00429492618003925,-0.00501106348795236,0.0118250471378015,0.42763466123399
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24013.Total traffic load on major roads,51761,0.0139317765045454,0.0286799667180071,-0.0422809582627485,0.0701445112718393,0.62713709038201
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24015.Sum of road length of major roads within 100m,51761,0.0101310219573147,0.0279656780566253,-0.044681707033671,0.0649437509483004,0.717156364653047
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51761,0.00289824155231096,0.00488245393939762,-0.00667136816890838,0.0124678512735303,0.552783163105646
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51761,0.00347030894769135,0.00488212614303544,-0.0060986582926581,0.0130392761880408,0.477203445436443
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51761,0.00330280851083259,0.0048249475110913,-0.00615408861090635,0.0127597056325715,0.49364907743941
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51724,-8.3914311034406e-05,0.00471406005435342,-0.00932347201756711,0.00915564339549829,0.985797874299889
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24020.Average daytime sound level of noise pollution,51761,0.000842879035452014,0.00423980262725336,-0.00746713411396456,0.00915289218486859,0.842419783536208
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24021.Average evening sound level of noise pollution,51761,0.000890144266823499,0.00423996731591497,-0.00742019167236984,0.00920048020601683,0.833715331292245
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24022.Average night-time sound level of noise pollution,51761,0.00086180669260035,0.00423996258733416,-0.0074485199785746,0.0091721333637753,0.838935097481296
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51761,0.00084492056719714,0.00423978747780094,-0.0074650628892927,0.00915490402368698,0.84204257254487
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51761,0.0008474100324183,0.00423983032908443,-0.00746265741258717,0.00915747747742377,0.841584903909764
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2405.Number of children fathered,51751,-0.0694898539481586,0.0215874525341601,-0.111801260915112,-0.0271784469812049,0.00128818983285498
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",49260,-0.0050222172545888,0.00503395212651754,-0.0148887634225632,0.00484432891338559,0.31845164500213
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",49260,0.00468195434540992,0.00452283539216753,-0.00418280302323843,0.0135467117140583,0.300596394956571
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24502.Water percentage, buffer 1000m",49260,-0.00516186822623191,0.00457373501612227,-0.0141263888578316,0.00380265240536775,0.259084247453754
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",49260,-0.0100914009143493,0.00472924128639535,-0.0193607138356842,-0.000822087993014455,0.0328683725305194
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",49260,0.00990994621424854,0.00456828081750659,0.00095611581193563,0.0188637766165614,0.0300717009198637
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24505.Water percentage, buffer 300m",49260,-0.00610929428332281,0.00460376186263548,-0.0151326675340883,0.00291407896744273,0.184515998171736
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51835,-0.00390276750214509,0.00482420702888993,-0.0133582132787693,0.00555267827447917,0.418525335791463
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51835,-0.00781599571579677,0.00451939062139217,-0.0166740013337254,0.00104200990213188,0.083744417367319
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24508.Distance (Euclidean) to coast,51835,-0.00550750894473323,0.00427575983355302,-0.0138879982184972,0.00287298032903069,0.197731903010049
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2867.Age started smoking in former smokers,35445,0.0038004610889714,0.00779594987129,-0.011479600658757,0.0190805228366998,0.625925514064365
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",36968,0.0453405601993606,0.0431181262869265,-0.0391709673230153,0.129852087721737,0.293039682108169
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,36966,-0.0282678440386085,0.0491266949345445,-0.124556166110316,0.0680204780330988,0.565031551712036
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,36966,-0.00735887920171572,0.0458587656383602,-0.0972420598529018,0.0825243014494704,0.872516048327645
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",36955,-0.0394680018746471,0.046031172869194,-0.129689100698267,0.0507530969489732,0.391237965708556
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28739.Difficulty with standing for long periods,36974,0.0502460728826318,0.0399353425270025,-0.0280271984702931,0.128519344235557,0.208359733995135
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28740.Difficulty with taking care of household responsibilities,36990,0.0359106017125581,0.0464020826514276,-0.05503748028424,0.126858683709356,0.439011361183534
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28741.Difficulty learning a new task,36945,0.130648588908058,0.0551026655636048,0.0226473644033923,0.238649813412723,0.0177624717820872
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28742.Difficulty with joining in community activities,36520,-0.0112496853257315,0.0498525235640752,-0.108960631511319,0.086461260859856,0.821472244046897
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28743.Difficulty with being emotionally affected by health problems,36937,-0.0540143199930461,0.0435984201678294,-0.139467223521992,0.0314385835358996,0.215415409184327
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,36997,0.0492627603650165,0.0585247020565019,-0.0654456556657272,0.16397117639576,0.399955783510814
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,34847,-0.0595118005109124,0.0401966709413139,-0.138297275555888,0.0192736745340629,0.138786124740416
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2897.Age stopped smoking,35439,0.026237209853257,0.00820832616255286,0.0101488905746534,0.0423255291318606,0.00139780212892588
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,36028,-0.0312009276535337,0.0164324820900902,-0.0634085925501106,0.00100673724304306,0.05763805193761
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,36028,0.0225479604836286,0.0186229049974708,-0.0139529333114142,0.0590488542786714,0.226024027104807
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,36028,-0.128026998437108,0.0620617039359839,-0.249667938151637,-0.00638605872257998,0.0391569473842698
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,36028,-0.0289568563703023,0.061192135721469,-0.148893442384381,0.0909797296437769,0.636075802677798
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,36028,0.0187872751822055,0.0756189958239062,-0.129425956632651,0.167000506997062,0.803795824060419
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,36028,0.0861903724805104,0.0679541659804881,-0.0469997928412462,0.219380537802267,0.204709029572789
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,36028,0.0324546721858807,0.0278837313714816,-0.0221974413022233,0.0871067856739847,0.244490335392258
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,36028,0.124916211661803,0.0522815993408629,0.0224442769537119,0.227388146369894,0.016905496282314
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29002.Recent lack of interest or pleasure in doing things,35980,0.0221872603513481,0.0471665541978691,-0.0702591858764753,0.114633706579171,0.63808145381831
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29003.Recent feelings of depression,35981,-0.0374933175194955,0.0467656597027547,-0.129154010536895,0.0541673754979038,0.422736395435332
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",35985,-0.00316841671475266,0.0369696543640724,-0.0756289392683345,0.0692921058388292,0.931704702968839
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29005.Recent feelings of tiredness or low energy,35987,0.0203075754933808,0.0363463587603074,-0.0509312876768216,0.0915464386635833,0.576367177699802
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29006.Recent poor appetite or overeating,35993,-0.0244694685347877,0.0572343465114144,-0.13664878769716,0.0877098506275846,0.669004924350567
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29007.Recent feelings of inadequacy,35969,-0.000177398329190047,0.0512213964257521,-0.100571335323664,0.100216538665284,0.997236734809176
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29008.Recent trouble concentrating on things,35988,-0.00696299318161317,0.04884365871431,-0.102696564261661,0.0887705778984344,0.886644146467514
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,35986,-0.0367454551794879,0.0838413634526316,-0.201074527546646,0.12758361718767,0.661200790760029
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29010.Recent thoughts of suicide or self-harm,35965,-0.0128495992637105,0.0907399570437388,-0.190699915069439,0.165000716542017,0.887392690964376
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29038#0.Substances taken for depression_None of options listed,35902,-0.000749559075154978,0.0325298961143266,-0.0645081554592351,0.0630090373089252,0.98161727255545
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),35902,0.0229206756553357,0.0601228313939576,-0.0949200738768212,0.140761425187493,0.703043081425742
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),35902,0.0264059838209533,0.0360871564483436,-0.0443248428178002,0.0971368104597068,0.464358067879227
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),35902,-0.0346145916529598,0.107279153337636,-0.244881732194726,0.175652548888806,0.746962692266806
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),35902,0.043807764124359,0.07239260980063,-0.0980817510848758,0.185697279333594,0.545103863803062
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),35902,-0.0281817166388184,0.0817548860748593,-0.188421293345543,0.132057860067906,0.730322420347438
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),35902,0.0443066168436356,0.0851117525684022,-0.122512418190433,0.211125651877704,0.602682203164687
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),35902,0.0180866344425939,0.0983840189240763,-0.174746042648596,0.210919311533783,0.854146341412586
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),35902,-0.0194359023411463,0.0713813523844935,-0.159343353014753,0.120471548332461,0.785412409903199
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,35902,0.000205281063618418,0.0306993115634038,-0.0599653696006531,0.06037593172789,0.99466490437146
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,35902,-0.0393900455617173,0.0495007321548882,-0.136411480585298,0.0576313894618636,0.426205128714187
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,35902,0.0697077245048286,0.0793043830439763,-0.085728866261365,0.225144315271022,0.379435861777491
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,35902,0.0293509000129106,0.0952816506684898,-0.157401135297329,0.216102935323151,0.758057964011226
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,35902,0.0129584786935437,0.0577631599035281,-0.100257314717371,0.126174272104459,0.822500493276433
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,35902,0.165630118388289,0.0888927376044503,-0.0085996473164337,0.339859884093011,0.0624660705624369
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,35902,0.0627896069202361,0.0890287991357618,-0.111706839385857,0.237286053226329,0.480662865410646
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,35902,0.0591630810865353,0.0495839426445449,-0.0380214464967726,0.156347608669843,0.232833606004752
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,35902,0.083956539491096,0.046972742691394,-0.00811003618403627,0.176023115166228,0.0739230595152324
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,35902,0.080597015099138,0.0710561042442819,-0.0586729492196545,0.21986697941793,0.256717317980645
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29058.Recent feelings or nervousness or anxiety,35873,-0.0221119581905248,0.0454149980468591,-0.111125354362369,0.0669014379813191,0.626353306276832
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29059.Recent inability to stop or control worrying,35879,-0.0311347158081456,0.048444872750358,-0.126086666398847,0.0638172347825561,0.520449798597245
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29060.Recent worrying too much about different things,35877,-0.0132788391447076,0.0430966317011504,-0.0977482372789624,0.0711905589895473,0.758001522070626
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29061.Recent trouble relaxing,35875,-0.00333516693167617,0.0457366144129493,-0.0929789311810567,0.0863085973177044,0.94187086153603
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29062.Recent restlessness,35882,0.0641635263901971,0.0628235221538499,-0.0589705770313488,0.187297629811743,0.307132217347193
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29063.Recent easy annoyance or irritability,35869,0.0747830064755108,0.0440910887285876,-0.0116355274325209,0.161201540383542,0.0899092989048336
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29064.Recent feelings of foreboding,35874,-0.0958312043793875,0.0547176735240082,-0.203077844486444,0.0114154357276686,0.079923369619941
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,35902,0.0114490227943874,0.0386811978650621,-0.0643661250211343,0.0872641706099092,0.76725057651365
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,35902,0.07713236335086,0.0595119219866401,-0.0395110037429546,0.193775730444675,0.19498801066984
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',35902,0.074916496558033,0.0811575826461961,-0.0841523654285114,0.233985358544577,0.35598603156659
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,35902,0.0289553121962254,0.0798912197161987,-0.127631478447524,0.185542102839975,0.717038057672922
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#2.Symptoms of panic attack_Sweating,35902,0.074485520300786,0.0501921195393508,-0.0238910339963416,0.172862074597914,0.137849889694829
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,35902,0.117011280774772,0.0626018169559535,-0.00568828045889726,0.23971084200844,0.0616439591830874
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,35902,0.00800476198736587,0.0595780516009726,-0.10876821915054,0.124777743125272,0.893123537827896
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,35902,0.0603385958226164,0.0589050335730818,-0.055115269980624,0.175792461625857,0.305710136795764
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,35902,0.00533478251991479,0.0741653221066096,-0.14002924880904,0.15069881384887,0.942658824529762
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29076.Felt loved as a child,35841,-0.0640655435731829,0.0369347118730466,-0.136457578844354,0.00832649169798849,0.0828610068519933
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29077.Physically abused by family as a child,35852,0.0904374636006522,0.0477441448723058,-0.00314106034906723,0.184015987550372,0.058236835022008
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29078.Felt hated by family member as a child,35844,0.193664177996998,0.0540352264497853,0.0877551341554184,0.299573221838577,0.000340551025686708
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29079.Sexually molested as a child,35828,0.208397214864963,0.0803442981344702,0.050922390521401,0.365872039208524,0.00951126413860436
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29080.Someone to take to doctor when needed as a child,35839,-0.0636428705274327,0.0567857446326622,-0.174942930007451,0.0476571889525852,0.262429633120322
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,35850,0.000227595726969156,0.0811699254459552,-0.158865458147103,0.159320649601041,0.997762858410647
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,35824,0.116582850066489,0.0692485463882419,-0.0191443008544656,0.252310000987443,0.0923133897088582
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,35861,0.0272355190614818,0.0779586746745595,-0.125563483300655,0.180034521423618,0.726830380922043
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,35854,0.440252844408645,0.245884936849024,-0.0416816318154409,0.922187320632731,0.073417960277415
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,35847,0.0819281893868032,0.15241417793929,-0.216803599374205,0.380659978147811,0.590913561145248
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29086.Experienced a violent or sexual assault,35867,-0.0326440817119065,0.0831704988388628,-0.195658259436078,0.130370096012265,0.694703336036479
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29087.Experienced a life-threatening injury or illness,35859,0.0874199230026022,0.0424175178969759,0.00428158792452932,0.170558258080675,0.0393443922059921
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29088.Experienced a marital separation or divorce,35857,-0.0647600901740902,0.0419903262996803,-0.147061129721464,0.0175409493732832,0.123053514736322
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29089.Experienced the death of a spouse or partner,35868,0.00735500922557927,0.0646296289897414,-0.119319063594314,0.134029082045472,0.909397551113737
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,35861,-0.0487606546766345,0.0513744023152897,-0.149454483214602,0.0519331738613333,0.342589374751169
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29091.Frequency of drinking alcohol,35854,-0.377767093871004,0.0344413922215176,-0.445272222625178,-0.310261965116829,8.95531849135259e-28
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,35259,-0.311290648136622,0.0362955583721277,-0.382429942545993,-0.240151353727252,1.20269443193608e-17
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,35279,-0.338584379335568,0.0363396969734166,-0.409810185403465,-0.267358573267672,1.5902700610845e-20
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29104.Ever used cannabis,35848,-0.0624179748361783,0.0457815895374317,-0.152149890329544,0.0273139406571877,0.172803278111605
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29108.Ever thought that life not worth living,35822,0.0615433215178264,0.0458497792158445,-0.0283222457452289,0.151408888780882,0.179546859597054
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29109.Ever contemplated self-harm,35829,0.111242845612263,0.0639488478238403,-0.014096896122464,0.23658258734699,0.08197890909298
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29111.Ever self-harmed,35840,-0.0484274328890813,0.110894127229859,-0.265779922259604,0.168925056481441,0.662342166373705
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,35843,0.0173688606570591,0.0688759928016511,-0.117628085234177,0.152365806548295,0.800912315504111
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,36505,0.0344267947544473,0.0766371490135991,-0.115782017312207,0.184635606821101,0.653286644219669
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,36505,-0.0351480045619263,0.0598323719096336,-0.152419453504808,0.0821234443809555,0.556924161400052
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,36505,0.0874730153338548,0.0741504944182495,-0.0578619537259144,0.232807984393624,0.238167518289158
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,36505,0.0938062520831639,0.120729238677201,-0.142823055724149,0.330435559890477,0.437183810506394
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,35832,0.0232400291850159,0.03929331237923,-0.0537748630782749,0.100254921448307,0.554237442987656
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X29153.Pain or discomfort today,35846,-0.0857901685334505,0.0360636653595666,-0.156474952638201,-0.0151053844286999,0.0173923512400444
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29154.Anxiety or depression today,35846,-0.0190163725394768,0.0476929105109461,-0.112494477140931,0.0744617320619775,0.690107339246785
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29166.Frequency of confiding in someone close,35675,-0.00070208653250544,0.0358205513530851,-0.0709103671845523,0.0695061941195414,0.984362933865932
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,35830,0.0311754034870751,0.0155101181007441,0.000775572009616653,0.0615752349645336,0.0444678151559393
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,35830,-0.00317238637313957,0.0160244824578867,-0.0345803719905974,0.0282355992443183,0.843073145377654
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,35830,-0.112799661651889,0.0170130145402691,-0.146145170150817,-0.0794541531529618,3.59382386668275e-11
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,35830,0.0603829733349556,0.0235303746954533,0.0142634389318672,0.106502507738044,0.0103027637196609
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,35830,0.0494401585703405,0.046775251852093,-0.0422393350597619,0.141119652200443,0.290559416971081
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,35830,0.0128952033127627,0.0172728369636218,-0.0209595571359361,0.0467499637614614,0.455353680367461
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,35825,-0.00466934992612256,0.0181413284089357,-0.0402263536076365,0.0308876537553914,0.796887034059628
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,35825,-0.00459436683814868,0.0284169068965392,-0.0602915043553654,0.0511027706790681,0.871564555945292
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,35825,-0.113638600405714,0.0327656368910424,-0.177859248712157,-0.049417952099271,0.000526962473621741
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,35825,0.0781963539030701,0.0398408857116734,0.00010821790819017,0.15628448989795,0.0497174678062659
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,35825,-0.00283329555009769,0.0649962040016024,-0.130225855393238,0.124559264293043,0.965231066043761
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,35825,-0.0125999404991709,0.0264005262928433,-0.0643449720331438,0.039145091034802,0.633190743770515
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29171.Frequency of feeling 'in tune' with people,35650,-0.0638287123762581,0.0439115893202293,-0.149895427443908,0.0222380026913913,0.146109170505182
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29172.Freuency of feeling that lacks companionship,35786,0.0356769720300652,0.0411191377198928,-0.0449165379009247,0.116270481961055,0.385615578956811
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29173.Frequency of feeling left out,35758,0.0518823811510983,0.0426857557834445,-0.0317817001844529,0.13554646248665,0.224234784659113
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29174.Frequency of feeling isolated from others,35791,0.0822553818309194,0.0437093986157944,-0.00341503945603755,0.167925803117876,0.0598941020999456
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29175.Tendency to bounce back quickly after hard times,35840,-0.0157363079127223,0.0356230812036447,-0.0855575470718659,0.0540849312464213,0.658687145968546
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29176.Ability to make it through stressful events,35840,0.0353386230158011,0.0344300042388641,-0.0321441852923726,0.102821431323975,0.304741944025787
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29177.Quick recovery from stressful events,35840,-0.0118907180750926,0.0351793519441509,-0.0808422478856283,0.0570608117354431,0.735370911461386
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29178.Hard to snap back when something bad happens,35840,0.0226361433264802,0.0345829543983377,-0.0451464472942617,0.0904187339472222,0.512780736964509
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29179.Comes through difficult times with little trouble,35840,-0.0256554344039898,0.0352927497881388,-0.0948292239887418,0.0435183551807622,0.467291035199476
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29180.Tendency to take a long time to get over setbacks,35840,0.0603991889397397,0.0348171272828831,-0.00784238053471111,0.128640758414191,0.0828267685076763
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29181.General happiness,35804,0.0511777588729425,0.0358175370307374,-0.0190246137073029,0.121380131453188,0.153091766082646
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29182.Belief that own life is meaningful,35704,-0.0457953706660591,0.0363376708124679,-0.117017205458496,0.025426464126378,0.207612455091571
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,34779,-0.041078156911484,0.0365166791602485,-0.112650848065571,0.0304945342426031,0.260668794240041
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2946.Father's age,33497,-0.0147247258367926,0.0144047929389396,-0.0429581199971143,0.0135086683235291,0.306731932769303
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2966.Age high blood pressure diagnosed,35460,-0.0172942956428784,0.0106213492459941,-0.0381121401650268,0.00352354887927005,0.103516136106658
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30000.White blood cell (leukocyte) count,51399,0.0444194893000763,0.0045454829921731,0.0355103426354171,0.0533286359647356,1.64036946396087e-22
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51400,-0.0585680691939395,0.00487305401698867,-0.0681192550672373,-0.0490168833206417,3.56768929274624e-33
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30020.Haemoglobin concentration,51400,-0.0851691824382616,0.0051162498453245,-0.0951970321350976,-0.0751413327414255,7.40408757063121e-62
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30030.Haematocrit percentage,51400,-0.0743126576250744,0.0050278286901931,-0.0841672018578529,-0.0644581133922959,3.3188239668079e-49
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30040.Mean corpuscular volume,51400,-0.00749101352002515,0.00451139245817391,-0.016333342738046,0.00135131569799572,0.0968345050026123
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51400,-0.0158987256494373,0.00452922496381161,-0.0247760065785081,-0.00702144472036655,0.000448544348369081
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51400,-0.0199065484387774,0.00440481902395179,-0.0285399937257229,-0.0112731031518319,6.23661486293458e-06
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51400,0.0593242037796326,0.00459559099991449,0.0503168454198002,0.068331562139465,5.44608544160516e-38
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30080.Platelet count,51400,-0.0112763252405376,0.00450987943770891,-0.020115688938447,-0.00243696154262813,0.0124136562750094
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30090.Platelet crit,51400,0.00925700543972348,0.00458624033305142,0.000267974386942699,0.0182460364925043,0.0435581750089488
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51400,0.0379059983376674,0.00425223654590821,0.0295716147076873,0.0462403819676475,5.26609584177214e-19
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30110.Platelet distribution width,51400,1.6474503458364e-05,0.00437123423268905,-0.00855114459261217,0.0085840935995289,0.996992937004296
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30120.Lymphocyte count,51366,0.00848858662003913,0.0044176859538723,-0.000170077849550579,0.0171472510896288,0.0546810852242238
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30130.Monocyte count,51366,0.0573181312228113,0.00442453121421358,0.0486460500429527,0.0659902124026699,3.0205132376919e-38
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30140.Neutrophill count,51366,0.0377085723678913,0.00449402651444811,0.0289002803995731,0.0465168643362096,5.10490961728922e-17
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30150.Eosinophill count,51366,0.0372855445879376,0.0042855427222136,0.0288858808523989,0.0456852083234763,3.53010182508036e-18
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30160.Basophill count,51366,0.0833157588385817,0.0210738512370906,0.0420110104138841,0.124620507263279,7.72446119942498e-05
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30170.Nucleated red blood cell count,51366,0.224410507199528,0.104127997721988,0.0203196316644328,0.428501382734624,0.0311612609828884
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30180.Lymphocyte percentage,51367,-0.0274539679902901,0.0043682895608721,-0.0360158155295994,-0.0188921204509808,3.34158613070251e-10
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30190.Monocyte percentage,51367,0.0303955709022787,0.004380801176181,0.0218092005969639,0.0389819412075934,4.0731687611057e-12
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30200.Neutrophill percentage,51367,0.00828264487841315,0.00431223520652315,-0.000169336126372221,0.0167346258831985,0.0547780740481399
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30210.Eosinophill percentage,51367,0.0247485274581933,0.00424803787008537,0.016422373232826,0.0330746816835606,5.75798367492225e-09
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30220.Basophill percentage,51367,0.00653360075927733,0.00442760736166045,-0.00214450966957715,0.0152117111881318,0.140051585618474
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30230.Nucleated red blood cell percentage,51365,0.226304429192868,0.104430678420505,0.0216202994886789,0.430988558897058,0.0302428910492718
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30240.Reticulocyte percentage,51020,-0.0761407040048011,0.00464965966735134,-0.0852540369528097,-0.0670273710567925,6.37290012261067e-60
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30250.Reticulocyte count,51020,-0.0879289443556997,0.0046850737766006,-0.0971116889578369,-0.0787461997535625,5.47927011914329e-78
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30260.Mean reticulocyte volume,51020,0.00907680507696421,0.00442980343729396,0.000394390339868041,0.0177592198140604,0.0404706865668279
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30270.Mean sphered cell volume,51020,0.00898009253134653,0.00445227175947123,0.000253639882782932,0.0177065451799101,0.0437106820434722
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30280.Immature reticulocyte fraction,51020,-0.0224876560465286,0.00460451717550241,-0.0315125097105133,-0.0134628023825439,1.04763921448775e-06
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,51020,-0.0697866676917965,0.0047195169183785,-0.0790369208518183,-0.0605364145317746,3.04051664776637e-49
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30300.High light scatter reticulocyte count,51020,-0.0791717095336822,0.00473379139497894,-0.0884499406678409,-0.0698934783995235,2.06692465399899e-62
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30500.Microalbumin in urine,36968,0.016239385841568,0.00708478788502807,0.00235320158691294,0.030125570096223,0.0219217848655534
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51442,0.0132822192752713,0.0047707857779796,0.00393147915043128,0.0226329594001113,0.00537249746080335
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30520.Potassium in urine,51395,-0.0259121076265558,0.00444488902611498,-0.0346240901177412,-0.0172001251353704,5.62955092031474e-09
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30530.Sodium in urine,51408,0.0263029283118845,0.00460296335128692,0.0172811201433621,0.0353247364804068,1.11498444369915e-08
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30600.Albumin,49249,-0.0797036510560253,0.00467502131042414,-0.0888666928244566,-0.070540609287594,9.89236865868461e-65
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30610.Alkaline phosphatase,50970,0.0539649826215577,0.0046291227309631,0.04489190206887,0.0630380631742454,2.58212566923004e-31
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30620.Alanine aminotransferase,50957,-0.0380769019973678,0.00500226089334975,-0.0478813333483333,-0.0282724706464023,2.80686633620694e-14
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30630.Apolipoprotein A,49185,-0.068395217600692,0.00507134453809931,-0.0783350528953667,-0.0584553823060174,2.80850748467059e-41
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30640.Apolipoprotein B,50812,-0.208984450925498,0.00411148979863589,-0.217042970930825,-0.200925930920172,0
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30650.Aspartate aminotransferase,50894,0.00539138183459203,0.004615546542311,-0.00365508938833753,0.0144378530575216,0.2427822493469
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30660.Direct bilirubin,49435,-0.0483726737920661,0.00468955311611051,-0.0575641978996427,-0.0391811496844895,6.92056751660696e-25
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30670.Urea,50953,0.0912389310554053,0.00450076490594287,0.0824174318397573,0.100060430271053,1.48564301229053e-90
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30680.Calcium,49239,-0.0487690102498523,0.00465278769208935,-0.0578884741263474,-0.0396495463733571,1.21638063343952e-25
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30690.Cholesterol,50973,-0.18863866251046,0.00419106483099033,-0.196853149579201,-0.180424175441719,0
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30700.Creatinine,50960,0.0804842846057114,0.00564019977492014,0.0694294930468679,0.0915390761645548,5.37872851791223e-46
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30710.C-reactive protein,50895,0.00147475166216381,0.00485068975892248,-0.00803260026532424,0.0109821035896519,0.761108429755831
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30720.Cystatin C,50978,0.0534719511963321,0.00522116501494735,0.0432384677670352,0.0637054346256289,1.4657669327044e-24
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30730.Gamma glutamyltransferase,50958,-0.108888213014019,0.00523791877207375,-0.119154533807283,-0.0986218922207541,4.3693464018e-95
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30740.Glucose,49215,-0.0293914059288588,0.00444050040614702,-0.038094786724907,-0.0206880251328107,3.70680501209475e-11
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50856,0.0453894110234446,0.00447313517223974,0.0366220660858547,0.0541567559610345,3.85216317744339e-24
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30760.HDL cholesterol,49227,-0.0461771105032497,0.00525128073828366,-0.0564696207502856,-0.0358846002562137,1.56136563014931e-18
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30770.IGF-1,50865,0.00739099028207263,0.00463964205728918,-0.00170270815021417,0.0164846887143594,0.111172428747024
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30780.LDL direct,50921,-0.194066089166197,0.00416977680462336,-0.202238851703259,-0.185893326629135,0
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30790.Lipoprotein A,46427,0.0219357173852527,0.00481158222120055,0.0125050162316996,0.0313664185388058,5.17540884607178e-06
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30810.Phosphate,49185,0.0539780278554605,0.00451863945256839,0.0451214945284265,0.0628345611824946,8.78234609070254e-33
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30830.SHBG,49094,0.123160054472349,0.00598436449594306,0.1114307000603,0.134889408884397,3.60503046328203e-93
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30840.Total bilirubin,50878,-0.137410677875114,0.00469565573208634,-0.146614163110003,-0.128207192640225,9.44861351377568e-185
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30850.Testosterone,50742,-0.0236617181381223,0.00748622740536983,-0.0383347238526472,-0.00898871242359742,0.00157602555734062
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30860.Total protein,49214,-0.0685571184648781,0.00460515354339334,-0.0775832194099291,-0.0595310175198272,7.26642175589046e-50
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30870.Triglycerides,50945,-0.0692909070690494,0.00457144910003197,-0.078250947305112,-0.0603308668329867,1.22475762207732e-51
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30880.Urate,50943,-0.0878806656137336,0.00546293935030056,-0.0985880267403227,-0.0771733044871445,6.69055516547553e-58
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30890.Vitamin D,50286,0.0253870929453872,0.00490902345031948,0.015765406982761,0.0350087789080133,2.34265753717679e-07
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X3137.Number of measurements made,49678,0.000155216728873837,0.0253217484570239,-0.0494754102468931,0.0497858437046407,0.995109232396802
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X3143.Ankle spacing width,41872,-0.0119502398037885,0.00788289649747541,-0.0274007169388403,0.0035002373312633,0.129550587085923
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",41871,-0.00409414679752993,0.00572948378504204,-0.0153239350162123,0.00713564142115247,0.474884166526926
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X3146.Speed of sound through heel,41872,-0.00829812121073712,0.00554087475286558,-0.0191582357263537,0.00256199330487942,0.134255959401424
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",41872,-0.00686652957006577,0.0055914619306738,-0.0178257949541864,0.00409273581405488,0.219454357372218
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X3148.Heel bone mineral density (BMD),41852,-0.00690091648768477,0.00562370218197984,-0.0179233727643653,0.00412153978899571,0.219802026374555
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X3526.Mother's age at death,42627,-0.00827399732903864,0.00564855112250743,-0.0193451575291532,0.00279716287107592,0.142997920821169
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32945,0.00672848593996413,0.0103341424427645,-0.0135264332478543,0.0269834051277825,0.515021002295533
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4100.Ankle spacing width (left),36115,-0.012693525587369,0.0109067117858913,-0.034070680687716,0.00868362951297791,0.244531079032203
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),36113,0.00671807445342686,0.00785409653684803,-0.00867595475879528,0.022112103665649,0.392379548789391
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4103.Speed of sound through heel (left),36115,-0.00888059808630439,0.00753329394744197,-0.0236458542232906,0.00588465805068186,0.238496579936176
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",36115,-0.00434905282950969,0.00763280888481167,-0.0193093582437406,0.0106112525847212,0.568841200297293
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4105.Heel bone mineral density (BMD) (left),36104,-0.00552857118060173,0.0076750658443199,-0.0205717002354687,0.00951455787426528,0.471344996179707
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",36115,-0.00435420724071962,0.00763328093888612,-0.0193154378809364,0.0106070233994972,0.568407156569585
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4119.Ankle spacing width (right),36108,-0.0161966937920804,0.0106735716035772,-0.0371168941350916,0.00472350655093084,0.129193259089394
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),36107,-0.00205567418920223,0.00789274460683182,-0.0175254536185926,0.0134141052401881,0.794522956861916
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4122.Speed of sound through heel (right),36108,-0.0178103220796557,0.00750498497597244,-0.0325200926325617,-0.00310055152674976,0.0176629776632091
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",36108,-0.0133544973062147,0.0076277338839656,-0.0283048557187873,0.00159586110635785,0.0800243490122109
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4124.Heel bone mineral density (BMD) (right),36096,-0.0136674102067519,0.007670807155396,-0.0287021922313281,0.00136737181782423,0.0748315543388702
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",36108,-0.0133612949295829,0.00762773802680846,-0.0283116614621275,0.00158907160296164,0.0798710552740141
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4194.Pulse rate,36493,0.0274670860860231,0.00709324685027357,0.0135643222594869,0.0413698499125593,0.000108689450578209
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4195.Pulse wave reflection index,36493,-0.0250639161955076,0.00743184823686895,-0.0396303387397707,-0.0104974936512444,0.000748468492225114
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4196.Pulse wave peak to peak time,36485,0.0153107858965068,0.00819124830562089,-0.000744060782510134,0.0313656325755237,0.0616370516822827
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4198.Position of the pulse wave peak,36493,-0.0222774851579003,0.00888647212902789,-0.039694970530795,-0.00485999978500569,0.0121994984133869
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4199.Position of pulse wave notch,36493,0.0342404700838948,0.00717031068092827,0.0201866611492754,0.0482942790185142,1.82661923898234e-06
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4200.Position of the shoulder on the pulse waveform,36493,-0.000406054180584866,0.00904891844349807,-0.0181419343298411,0.0173298259686713,0.964209491446948
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4269.Number of triplets attempted (left),36265,0.172746824830334,0.103474559086403,-0.0300633109790152,0.375556960639683,0.0950668026479713
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4270.Volume level set by participant (left),36179,0.0182827625927508,0.0318887580901875,-0.0442192032640167,0.0807847284495183,0.566438698707751
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4276.Number of triplets attempted (right),36269,0.189114630158828,0.101469965008678,-0.00976650125818018,0.387995761575836,0.0623950961048256
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4277.Volume level set by participant (right),36182,0.0120077895241263,0.0317344216933549,-0.0501916769948493,0.0742072560431019,0.705156134905653
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X4288.Time to answer,36454,0.00374666659703803,0.0084455738131749,-0.0128066580767848,0.0202999912708608,0.657326041211739
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X4290.Duration screen displayed,36454,0.0204124071330074,0.00794405696561609,0.00484205548039985,0.0359827587856149,0.0102022571673366
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X46.Hand grip strength (left),51988,-0.0437131808600026,0.00579915652808922,-0.0550795276550574,-0.0323468340649477,4.9512110447252e-14
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X47.Hand grip strength (right),51991,-0.0463202847395246,0.00572121934727347,-0.0575338746601806,-0.0351066948188686,5.94319664427473e-16
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X48.Waist circumference,52045,-0.0615658883685761,0.0108455801615675,-0.0828232254852485,-0.0403085512519037,1.39030752930648e-08
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X4803.Tinnitus,36306,0.00961156704792923,0.0366527055126084,-0.0622277357567832,0.0814508698526417,0.793148443981931
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X4825.Noisy workplace,36389,0.000368249643498414,0.0351036421637241,-0.0684348889974007,0.0691713882843976,0.991630330513086
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X4836.Loud music exposure frequency,36341,-0.00728345765176317,0.046425785741722,-0.0982779977055384,0.083711082402012,0.875340452574578
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X49.Hip circumference,52039,-0.0309859296660224,0.00799980539553215,-0.0466655482412654,-0.0153063110907793,0.000107647536519387
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X50.Standing height,51997,-0.0221349709368065,0.00605781625840799,-0.0340082908032861,-0.0102616510703268,0.00025879863877059
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X5057.Number of older siblings,35456,-0.003640835817854,0.0342033041244851,-0.0706793119018448,0.0633976402661368,0.915230895531504
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X51.Seated height,51896,-0.0149463001199882,0.00527812612065072,-0.0252914273164636,-0.00460117292351277,0.00463346337062071
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5181.Ever had eye surgery,33894,-0.00243712916265269,0.0774792627324445,-0.154296484118244,0.149422225792939,0.974907670280924
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5186.Duration visual-acuity screen displayed (right),33882,-0.000534280419005503,0.00936391475595079,-0.018887553340669,0.017818992502658,0.954501647095863
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5188.Duration visual-acuity screen displayed (left),33878,-0.00718991395351296,0.00964899863445176,-0.0261019512770384,0.0117221233700125,0.456216566144818
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5190.Duration at which refractometer first shown (right),33827,0.000701572063941288,0.00965578794512119,-0.0182237723084962,0.0196269164363788,0.942080901017222
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5193.Duration at which refractometer first shown (left),33823,-0.00132068244351459,0.00970484528511827,-0.0203421792023464,0.0177008143153172,0.891759446260345
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5199.logMAR, initial (right)",33860,0.0675322820663488,0.039436406445359,-0.00976307456655472,0.144827638699252,0.0868754860401952
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5200.Final number of letters displayed (right),33860,0.00490498048544474,0.245234392766971,-0.475754429337818,0.485564390308708,0.984043179580137
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5201.logMAR, final (right)",33798,0.0131863439650527,0.00927981874353777,-0.0050021007722813,0.0313747887023867,0.155385468142409
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5202.Number of rounds to result (right),33860,-0.000806460503070576,0.0366175593895165,-0.0725768769065228,0.0709639559003817,0.982429748827473
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5206.logMAR, initial (left)",33856,0.100202917397907,0.0396076009809092,0.022572019475325,0.177833815320489,0.0114387706206298
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5207.Final number of letters displayed (left),33856,-0.195743674107281,0.246736283858914,-0.679346790470751,0.28785944225619,0.427620514706681
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5208.logMAR, final (left)",33809,0.0155366692356304,0.00936210922925512,-0.00281306485370968,0.0338864033249704,0.0970699229610525
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5209.Number of rounds to result (left),33852,0.00292099687018284,0.0369196425536099,-0.0694415025348926,0.0752834962752583,0.936942032771754
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",33657,-0.0276079311403835,0.00927061560540514,-0.0457783377269776,-0.00943752455378943,0.00291509116281372
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",33657,-0.0401372433505453,0.00909132408445592,-0.0579562385560789,-0.0223182481450117,1.03164593044508e-05
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5256.Corneal hysteresis (right),33657,-0.0121190705495822,0.00943368331651392,-0.0306090898499495,0.00637094875078504,0.198970151319929
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5257.Corneal resistance factor (right),33657,-0.0311705271120141,0.0092921991295389,-0.0493832374059103,-0.0129578168181178,0.000800986030156253
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",33631,-0.0386057128621845,0.00933065254624243,-0.0568937918528197,-0.0203176338715493,3.56819905138908e-05
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",33631,-0.0438308691072813,0.00920852193059878,-0.0618795720912549,-0.0257821661233077,1.99200108882576e-06
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5264.Corneal hysteresis (left),33631,-0.00618702869953286,0.00936411603474581,-0.0245406961276347,0.0121666387285689,0.50882420515666
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5265.Corneal resistance factor (left),33631,-0.0305938925404339,0.00927444142093944,-0.0487717977254752,-0.0124159873553926,0.000977979446337073
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,34553,-0.0802298224337512,0.175415235217934,-0.424043683460901,0.263584038593398,0.647421176649024
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51980,0.0339020786510144,0.0237757154412448,-0.0126983236138253,0.0805024809158541,0.153907087867565
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51980,0.0242884372020805,0.0276216427859647,-0.0298499826584104,0.0784268570625714,0.379233412272753
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51980,0.123658127623105,0.0667820009346667,-0.00723459420884201,0.254550849455052,0.0640860390709507
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51980,0.0300078220842804,0.0107938916372717,0.00885179447522791,0.051163849693333,0.00543898763850354
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51980,-0.0347513529893148,0.010007218561369,-0.0543655013695981,-0.0151372046090315,0.00051631973909753
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",38845,-0.0385030300834205,0.0130335001629051,-0.0640486904027145,-0.0129573697641265,0.00314235388816569
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",38845,-0.040327180436672,0.0405825492818077,-0.119868977029015,0.0392146161556711,0.320388796944585
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",38845,-0.0192926443758923,0.0251969218231876,-0.0686786111493399,0.0300933223975554,0.443887551436402
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",38845,-0.0312653038301943,0.0151452226834915,-0.0609499402898376,-0.00158066737055095,0.0390080091582427
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,52049,-0.0123695545837442,0.0228077259562111,-0.057072697457918,0.0323335882904296,0.587589081523824
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,52049,-0.0123695545837442,0.0228077259562111,-0.057072697457918,0.0323335882904296,0.587589081523824
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),52049,-0.0534199976355781,0.0166040293840338,-0.0859638952282844,-0.0208761000428718,0.00129582879452555
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',52049,-0.0147823070075352,0.0291846371529619,-0.0719841958273405,0.0424195818122702,0.612503519168531
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),52049,-0.0644329902148594,0.0690486372373554,-0.199768319200076,0.0709023387703571,0.350750232632964
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),52049,0.00137327769586898,0.0480400604149155,-0.0927852407173655,0.0955317961091034,0.977194945984709
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,52049,0.166407543853374,0.0738254108085014,0.0217097386687113,0.311105349038037,0.0242010419696576
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51979,-0.00171840962090769,0.0147893975242939,-0.0307056287685238,0.0272688095267084,0.907501377874721
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51979,0.0479674829228742,0.0261641939341883,-0.00331433718813479,0.0992493030338832,0.0667668920253739
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51979,-0.0155502300735195,0.0135128172576781,-0.0420353518985685,0.0109348917515295,0.249836040095642
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51979,0.023786607066777,0.0200576811470115,-0.0155264479813656,0.0630996621149197,0.23566984839777
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51979,-0.00414455617456261,0.0202365496221978,-0.0438081934340704,0.0355190810849452,0.837725891518061
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51979,0.0373781336209041,0.011377482904277,0.0150782671285213,0.059678000113287,0.00102033610013359
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,37057,0.125858620302026,0.021234192227156,0.0842396035368004,0.167477637067252,3.2027973065866e-09
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,37057,0.0604502020345213,0.0202644554873602,0.0207318692792953,0.100168534789747,0.00286191259512038
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,37057,0.168416445352372,0.0293442907661216,0.110901635450773,0.22593125525397,9.83329501200449e-09
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,37057,-0.107059516465609,0.0219337528023341,-0.150049671958183,-0.0640693609730337,1.07458963168456e-06
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,51925,0.0144884402009634,0.0403595434696927,-0.0646162649996344,0.0935931454015611,0.719610125520713
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,51925,-0.0102208506982108,0.0491649574346371,-0.1065841672701,0.0861424658736779,0.835317503111634
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,51925,0.288972119087403,0.0983503282177549,0.0962054757806034,0.481738762394203,0.00330455945221695
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,51925,0.0827814832108708,0.0961080797629496,-0.10559035312451,0.271153319546252,0.389061098934059
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,51925,0.015627487899993,0.0377548230286815,-0.0583719652362227,0.0896269410362088,0.67893627796445
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,51925,0.0957866900385575,0.0445522306986011,0.0084643178692994,0.183109062207816,0.0315665397430758
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,51925,0.00304006788404546,0.0187662326794483,-0.0337417481676731,0.0398218839357641,0.87130985077181
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",35616,0.0142259030865966,0.0319623104854676,-0.0484202254649199,0.076872031638113,0.656273006097932
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",35616,0.0250091696790103,0.0313722304853663,-0.0364804020723078,0.0864987414303283,0.425376160419018
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",35616,0.0277960926197339,0.0443914289401315,-0.0592111081029238,0.114803293342392,0.531231028463609
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",35616,0.0120250157419521,0.0160778867142183,-0.0194876422179158,0.0435376737018201,0.454531878767848
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",38715,0.0749131479467112,0.0135545057471025,0.0483463166823904,0.101479979211032,3.34199082556143e-08
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",38715,-0.0471510294055966,0.0150232145534037,-0.0765965299302678,-0.0177055288809253,0.00170277100271483
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",38715,-0.00292739796994595,0.0132930086418238,-0.0289816949079207,0.0231268989680288,0.82570358551131
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",38716,-0.0090969520655584,0.030855269926854,-0.0695732811221922,0.0513793769910754,0.768132451216694
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",38716,-0.0148443294088054,0.0184139490705839,-0.05093566958715,0.0212470107695391,0.420177682596312
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",38716,0.0584704322594747,0.033211397228848,-0.00662390630906736,0.123564770828017,0.0783442660484691
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51979,0.0513709046753392,0.02944613965518,-0.00634352904881346,0.109085338399492,0.0810725746697146
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51979,0.0647235172980325,0.0237081108497484,0.0182556200325256,0.111191414563539,0.00633787036564263
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51979,0.0493409168627555,0.0466869586386931,-0.042165522069083,0.140847355794594,0.290592881141953
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51979,0.0234591902933,0.0264537321783643,-0.028390124776294,0.075308505362894,0.375195290359609
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51979,-0.00293033839703827,0.027097686471435,-0.0560418038810509,0.0501811270869743,0.913885725372343
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51979,0.0864932442816368,0.0326902184719982,0.0224204160765204,0.150566072486753,0.00815417285556077
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51979,-0.010152364807111,0.00946445849431748,-0.0287027034559732,0.0083979738417513,0.283424391456727
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,34139,0.0952420225616946,0.0236470225734699,0.0488938583176936,0.141590186805696,5.70896957641056e-05
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,34139,0.0908048950425014,0.0282486419013171,0.0354375569159199,0.146172233169083,0.00131427434966894
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,34139,-0.0754747287804552,0.0211356676635312,-0.116900637400976,-0.0340488201599341,0.000358686809077706
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,34139,0.0071795583869041,0.0187276736017982,-0.0295266818726204,0.0438857986464286,0.701462921171726
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,52084,0.0341720775876849,0.0114924931556559,0.0116467910025992,0.0566973641727705,0.00294794442210716
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,52084,0.0805863647404788,0.0379208313114395,0.00626153537005748,0.1549111941109,0.0335869067692228
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,52084,0.00855730096280156,0.0101257468537784,-0.0112891628706042,0.0284037647962073,0.398061837367966
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,52084,-0.00431652525593369,0.00944873746309861,-0.022836050683607,0.0142030001717396,0.647793014257655
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,52084,0.0264383175390913,0.0159940316132117,-0.00490998442280375,0.0577866195009863,0.0983418983375827
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,52084,0.034229355553103,0.0144454008055363,0.00591636997425192,0.0625423411319542,0.0178169298116998
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,52084,-0.00730457062204759,0.0102040047465751,-0.0273044199253348,0.0126952786812396,0.474089045451105
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,52084,0.0437215352241288,0.0330735260961469,-0.0211025759243192,0.108545646372577,0.186197804188378
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,44947,0.000115483252814472,0.0105477961168859,-0.0205581971362819,0.0207891636419108,0.991264615530944
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,44947,-0.118318756166358,0.0103379827674648,-0.13858120239059,-0.0980563099421274,3.24489967302345e-30
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,44947,0.101301364383317,0.0134139372511116,0.0750100473711378,0.127592681395495,4.51390309040382e-14
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,44948,0.0387058041261359,0.0208992298821891,-0.00225668644295482,0.0796682946952266,0.0640408817638684
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,44948,0.0505118289750125,0.0118748181030509,0.0272371854930328,0.0737864724569922,2.11442974276457e-05
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51861,-0.029473170956196,0.0108542220119323,-0.0507474460995834,-0.00819889581280862,0.00662516898932052
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51861,-0.0128288348172534,0.00852748752432815,-0.0295427103649366,0.00388504073042973,0.132489489239371
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51861,0.0278951173533048,0.00962724133894586,0.00902572432897097,0.0467645103776387,0.00376477553915922
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51861,-0.00736026634694305,0.0147321121778047,-0.0362352062154402,0.0215146735215541,0.617356554544011
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51883,-0.0231313662093235,0.00917733501782694,-0.0411189428442643,-0.00514378957438272,0.0117258380871612
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51883,-0.00815580345618668,0.0128270005580014,-0.0332967245498694,0.016985117637496,0.524892886950249
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51979,-0.00239153130862805,0.00937865193116618,-0.0207736890937138,0.0159906264764577,0.798727395595526
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51979,0.00706062083786667,0.0117861954459003,-0.016040322236098,0.0301615639118313,0.549139663707588
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51979,0.0766603668070277,0.0251580832130869,0.0273505237093773,0.125970209904678,0.00231282698283372
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51979,0.0215365680382199,0.0230288051441103,-0.0235998900442363,0.0666730261206761,0.349694238534476
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51979,0.107441823762193,0.0279510828816929,0.0526577013140748,0.162225946210311,0.000121403181661165
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51979,0.0296556280716542,0.0287305745276632,-0.0266562980025656,0.085967554145874,0.301990269225912
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",41872,-0.00686374134281728,0.00559148054595142,-0.0178230432128821,0.0040955605272475,0.219643127122866
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X864.Number of days or week walked 10+ minutes,51612,-0.0177366320447375,0.0187950491600068,-0.0545749283983509,0.0191016643088758,0.345339842115705
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X874.Duration of walks,48979,-0.00467460366271632,0.00439265798783297,-0.0132842133188689,0.00393500599343629,0.287257208472054
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,51012,-0.0323211820262751,0.0182446704275767,-0.0680807360643255,0.00343837201177533,0.0764843676926367
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X894.Duration of moderate activity,46264,0.0308154092529089,0.0218962055317916,-0.0121011535894025,0.0737319720952203,0.159344144774322
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X90087.No-wear time bias adjusted average acceleration,33301,0.00528376040831066,0.00978888984164184,-0.0139024636813073,0.0244699844979287,0.589380425675429
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50946,-0.0365780319136456,0.0185737429989914,-0.0729825681916687,-0.000173495635622481,0.0489262941093579
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X914.Duration of vigorous activity,41961,0.0156163751353959,0.00525650067154074,0.00531363381917604,0.0259191164516157,0.00297486762808377
